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ABSTRACT 
 
 
The Fundamental Chemistry Related to the Separations and Coordination of Actinium-225, 
Thorium-227, and Technetium-99 
By  
Jasmine Latoya Hatcher 
 
This work explores the fundamental chemistry of actinium, thorium, and technetium in an 
effort to develop methodologies which help to address complications specific to each of these 
elements. Developing fundamental knowledge in inorganic chemistry has the power to 
meaningfully address a number of real world problems. By using simple systems and 
experiments like following an electron or changing the solvent system, we are able to gain 
invaluable information which can be used to address major issues.  
Actinium-225 (t½: 9.92 d) is an alpha-emitting radionuclide with nuclear properties well 
suited for alpha therapy of malignant tumors. The present global supply of 225Ac is 1.7 Ci per 
year yet the global demand is 50-100 Ci. Currently, the production of 225Ac from proton 
irradiation of 232Th metal targets is being investigated at Brookhaven National Laboratory. One 
proposed method for separation of 225Ac from bulk thorium targets involves the use of 
polyoxometalates (POMs), large metal oxide clusters that have been used to chelate high-valent 
actinides and lanthanides. The modified Wells-Dawson POM ([P2W17O61]10- ) has a very high 
 vi 
affinity for thorium. Our study seeks to take advantage of the affinity of POMs for thorium to 
separate 225Ac from bulk thorium for 225Ac production. The separation is carried out by adding 
the POM to aqueous solutions of thorium, lanthanum, and actinium as individual metals and as 
mixed metal solutions, and contacting those solutions with 3% octylamine in chloroform. The 
extractions are quantified using ICP-OES. This study has shown that the POM completely 
extracts the thorium from the aqueous solution and preferentially extracts thorium over 
lanthanum and actinium.  
Thorium-227 (t½: 18.7 d) is an alpha emitting nuclide which may also be a candidate for 
targeted alpha therapy. With its longer half-life, 227Th delivers a lower dose of radiation over 
time, which may make it a better isotope for treating malignant tumors. Thorium has been found 
to treat ovarian and bone cancers in mice. In the past 3,4,3-LI(1,2-HOPO) was successfully 
coordinated to zirconium, found to exhibit high stability in vivo and ultimately built into an 89Zr-
based imaging agent. Thorium and zirconium have very similar chemical behavior. Both are +4 
oxophilic metals which prefer octadentate ligands. This work investigated the labeling and 
stability of Th-HOPO in comparison to the standard ligand for labeling, 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA). It was found that HOPO had higher 
yields and higher stability. The development of radiolabeling methods required additional 
purification of the thorium to separate its many daughter radionuclides. Purification of the 
thorium was carried out using 8M nitric acid and an anion exchange resin. 
Technetium-99 (99Tc, t½: 2.1 x 105 years; bmax: 293.7 keV) is a high-yield fission product 
(6%) in light-water reactors. The removal and permanent storage of technetium from nuclear 
waste streams is of great importance for the nuclear fuel cycle and for remediation of legacy 
waste. A fundamental study of the reduction, coordination, and spectroscopic behavior of 
 vii 
technetium has been conducted in aqueous and organic media including ionic liquids (ILs). In 
order to ascertain the value of using ILs in nuclear waste remediation, the behavior of technetium 
in ILs must be understood. This work sought to understand the behavior of technetium, using 
electrochemistry and spectroscopy to investigate the behavior of well-known technetium 
complexes in neat ILs and acid-IL mixtures to probe the effect of ILs on technetium redox 
chemistry. Titration of bistriflimidic acid (HNTf2) into TcO4- in the IL trimethylbutylammonium 
bistriflimide (N1114 NTf2) showed that the TcO4- anion is protonated in the IL to form HTcO4 
(pertechnic acid). This protonation was monitored using UV-Vis and x-ray absorption 
spectroscopy, specifically, EXAFS and XANES, to understand the speciation of TcO4- in this IL. 
This study has found that technetium is more reactive in ILs.  
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1. Introduction 
This body of work examines four projects that span the field of radiochemistry. The first 
project focuses on separations as it seeks to address the issue of the global supply of actinium for 
radiotherapy. The second project explores radiolabeling and separations by studying the effect of 
purity on the chelation of common ligands to thorium-227. The final two projects address the 
issue of nuclear waste management and remediation by studying the chemical and 
electrochemical behavior of the nuclear waste product technetium-99 in ionic liquids as well as 
aqueous media. While these projects seem quite different, this work overwhelmingly focuses on 
the basic inorganic chemistry of radiometals and the development and manipulation of that 
chemistry to advance medical and environmental applications. 
Actinium-225 is an important radionuclide for targeted alpha therapy for the treatment of 
malignant tumors.3-7 The demand for actinium is roughly 50 times higher than the supply.8 The 
current supply of 225Ac is obtained from a 229Th generator and can only be isolated from the 
generator every 9 weeks.9 It was found that 225Ac can also be made from thorium-232 by 
irradiating a thorium target with a high energy proton beam.10-12 Brookhaven National 
Laboratory (BNL), Oak Ridge National Laboratory (ORNL), and Los Alamos National 
Laboratory (LANL) are working together to increase the amount of globally available 225Ac, 
since all three of these facilities have linear accelerators and are capable of irradiating 232Th to 
produce 225Ac. Separating actinium from the bulk thorium as well as the other 400 isotopes 
created requires several columns and generates a lot of solvent waste.10-12 This work examines 
the use of nano-sized metal oxide clusters called polyoxometalates to separate thorium from 
actinium in order to reduce the amounts of waste and time needed for debulking the targets.   
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Thorium-227 is another potentially important radionuclide for targeted alpha therapy. It is 
an alpha emitter with four alpha-emitting nuclides in its decay chain, similar to 225Ac. However, 
227Th has a longer half-life, which provides a lower the dose rate than other alpha-emitting 
nuclides. This may be useful for treating cancer cells at different developmental stages, which is 
a more efficient way of killing tumors. There have been reports that 227Th is toxic3, however 
those reports do not take into consideration that the thorium being used may have partially 
decayed to 223Ra and subsequent daughters that may be the cause of the toxicity. Thorium can be 
separated from its daughters using a small column and an anion exchange resin. This usually 
requires the use of large amounts of acid, and more importantly, a long evaporation process. 
Boiling solutions with alpha emitting isotopes is undesirable due to the risk of volatilization and 
contamination. This work aims to circumvent these problems by streamlining the purification 
and synthesis of 227Th as well as examining the stability of thorium complexes. 
Technetium-99 is a high-yield waste product of spent nuclear fuel and weapons 
production during the cold war era. Legacy waste from weapons production is currently buried 
underground at waste sites like Hanford site and Savannah River. Due to its extremely long half-
life, 99Tc is a large contributor to the radioactive dose from the waste tanks.13  The waste tanks 
are slowly leaching radioactive materials into the environment, and while there are plans to 
address this, technetium complicates the current storage strategies. These complications exist due 
to the myriad of technetium complexes with various oxidations states in the waste tanks. The 
current plan for dealing with the tank waste is to contain the waste within borosilicate glass. This 
process requires high temperatures and has low yield because technetium volatilizes under these 
conditions.14 To address this issue, either an alternative means of storage for technetium-99 
needs to be investigated or the technetium must be separated from the rest of the tank waste. 
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Ionic liquids (ILs) have been shown to extract and deposit other metallic fission products (i.e. 
strontium).15 These unique solvents are salts that are liquid at or near room temperature, typically 
comprised of a large organic cation and a relatively small inorganic anion, and they 
simultaneously exhibit polar and non-polar properties. To examine the feasibility of applying ILs 
to the technetium problem, we must first understand the fundamental behavior of technetium in 
ILs. This work examines the speciation of technetium in ILs as well as the electrochemical 
behavior of simple technetium complexes in ILs. 
The common thread in this body of work is to use the fundamental chemistry of 
radiometals to address real world problems. We are trying to address very large problems in 
small steps by conducting simple, impactful experiments. Basic principles like solubility and 
“hard and soft” acid base theory have a significant impact on the chemical behavior of a 
material. These principles can be exploited to find new avenues of chemistry that can help 
address some of the radiochemical issues which affect the world. 
1.1 Radiochemistry 
Radiochemistry is the study and manipulation of elements that are radioactive, meaning 
that these materials undergo radioactive decay. Radioactivity is the decay of an unstable nucleus 
via the emission of high energy photons or particles. There are four major modes of nuclear 
decay: alpha, beta, gamma, and electron capture. The mode of decay is dependent upon the type 
of nuclear instability, for example an excited nucleus usually results in gamma decay, an excess 
of overall nucleons results in alpha decay, an excess of neutrons usually results in beta decay (or 
less commonly neutron emission), and an excess of protons typically results in electron capture. 
A less common but very important mode of decay is nuclear fission. This occurs when a heavy, 
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unstable nucleus is activated by a neutron and splits, generating other elements rather than 
subatomic particles.  
Alpha decay by the emission of an alpha particle typically occurs in heavy nuclides 
(Figure 1.1). The emission of an alpha particle reduces the size of the nucleus and therefore 
brings the atom to a more stable state. Alpha decay results in the atomic number of the element 
decreasing by two and the total number of nucleons decreasing by four. 
	
Figure 1.1. Alpha decay of 226Ra to 222Rn.  
 
Beta decay is the emission of an electron (negative beta particle, b- decay), or positron (a 
positive beta particle, b+ decay), from the nucleus of an atom (Figure 1.2). Beta decay is usually 
accompanied by a neutrino or an antineutrino emission for b+ and b- respectively. b- decay occurs 
in neutron-rich nuclei, converting a neutron to a proton in an effort to become more stable, 
whereas b+ decay occurs in proton-rich nuclei, converting a proton to a neutron to become more 
stable. b- decay results in the atomic number of the element increasing by 1 and b+ decay results 
in the atomic number of the element decreasing by 1.  
	
Source: By PerOX [CC0], via Wikimedia Commons 
https://upload.wikimedia.org/wikipedia/commons/a/a1/Alpha-decay.png l 
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Figure 1.2. Beta decay of carbon-14 and carbon-10. 	
 
  
 
Gamma decay is the de-excitation of the nucleus to a lower energy state via the emission 
of a high energy photon called a gamma ray. During the process of gamma decay the mass of the 
atom does not change; the nucleus simply transitions to a lower energy state. 
Electron capture (EC) arises from the nucleus of the atom absorbing an electron from the 
electron shell closest to it. The capture of an electron causes the electrons from the outer shells to 
fill the vacancy, resulting in the emission of a high-energy photon (X-ray) or the emission of an 
electron (Auger effect). The latter is typically accompanied by the emission of an electron 
neutrino. EC usually occurs in proton-rich nuclei which attempt to reach a more stable state by 
the “neutralization” of a proton. EC decreases the atomic number by 1 as shown by the decay of 
carbon-11 to boron-11 in Figure 1.3.  
Source: https://education.jlab.org/glossary/betadecay.html 
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Figure 1.3. Electron capture decay of carbon-11 to boron-11  
 
1.2 Facilities  
Facilities for research with radioactive materials must have specific instrumentation 
present in order to successfully and safely complete experiments. There are two separate 
concerns when working with radioactive materials: radiation dose and contamination. Radiation 
dose to personnel must be monitored and must not exceed 5 rem per year. The radiation dose can 
be kept low by increasing the distance from the source of radiation, minimizing the time that the 
material is being handled, and utilizing shielding where applicable. The dose is also mitigated by 
working with very small amounts of material. Minimizing contamination can be accomplished 
by using HEPA-filtered hoods and Geiger counters. Without these protocols and equipment work 
with radioactive materials is unsafe and impractical. Notably, working with very small quantities 
has the potential to make the experiment below the limit of detection of standard analytical 
instruments. Fortunately, there are other methods which can be used to determine or detect small 
amounts of radioactive materials.  
1.2.1 Analysis/Characterization/Instrumentation  
The particles emitted from radioactive materials have high energies and they can ionize 
other materials upon contact with them. The emitted photons can also ionize materials, and they 
source: https://education.jlab.org/glossary/electroncapture.gif 
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can be observed with special detectors. There are several means by which radioactivity can be 
detected. In research, the most commonly used detectors are gas-filled detectors, scintillation 
detectors, solid-state semiconductor detectors, and special neutron detectors. 
Gas-filled detectors have a volume of an inert gas which is either sealed within or 
continuously flowed through a chamber with an applied electric field. The electric field is 
generated by a voltage applied across a cathode and an anode. As ionizing radiation passes 
through the chamber, it creates a cation/anion pair from the inert gas. The ions are attracted to 
the oppositely charged electrodes and when the ions come into contact with the electrodes, a 
signal is created that indicates the presence of ionizing radiation. The most common types of gas 
detectors are ionization chambers (i.e dose calibrators), proportional counters (i.e. iTLC), and 
Geiger-Muller counters (see figure 4). This method of detection is simple, robust, relatively 
inexpensive, and allows for fast detection of radioactivity. However, this method cannot 
distinguish between isotopes or measurable energies of emitted particles. In this work, ionization 
chambers are used to quickly quantify the labeling reactions of 227Th, proportional counters are 
used to determine radiochemical yield of 225Ac, and Geiger counters are used to monitor for 
possible contamination of 99Tc, 227Th, and 225Ac. 
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Figure 1.4. Principle of gas filled counters for the detection of ionizing radiation  
 
Scintillation detectors work similarly to gas-filled detectors in that the emitted particle 
comes into contact with the scintillator, which is either an organic molecule (liquid scintillation) 
or a crystal (solid scintillation) and excites it. The de-excitation of the scintillator results in a 
photon, which is then amplified and converted to an electrical signal via a photomultiplier tube. 
Scintillation counters cannot specifically distinguish between isotopes, but they can give 
information about the energy of the particle emitted, which may be indicative of a radioisotope. 
Scintillation counters are commonly used to quantify the amount of activity in a specific sample. 
Liquid scintillation counting was used to quantify 99Tc. Solid scintillation is used to monitor 
alpha contamination from 227Th and 225Ac in the form of Geiger probes fitted with a zinc sulfide 
crystal.16 Figure 1.5 shows the alpha probe attachment for Geiger counters. 
Source: Svjo-2 - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=39176160 (A) 
Geiger counter. Source: By TimVickers - http://fathersonpreppers.com/top-7-geiger-counters-how-they-work/, 
Public Domain, https://commons.wikimedia.org/w/index.php?curid=4375382 (B) and Dose calibrator (C)  
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Figure 1.5. Alpha probe attachment for a Geiger counter. Source: https://ludlums.com/products/all-
products/product/model-43-90 
 
Solid state semi-conductive detectors utilize high-purity semiconductors such as 
germanium or silicon to detect radiation. Upon contact with ionizing radiation, a pair of positive 
and negative charges is generated. Unlike the gas filled counters, the positively and negatively 
charged species created in this system are not a cation and an anion, they are an electron and a 
hole (the lack of an electron). Both the electron and the hole move through the semiconductor 
and generate a signal. This method is very sensitive and can identify radioisotopes based on their 
specific gamma energies or alpha particle energies. High purity germanium is used to detect 
gamma energies (gamma spectroscopy), and silicon is used to detect alpha particles (alpha 
spectroscopy). Gamma spectroscopy was used for the detection of 227Th, which has a distinct 
gamma energy, and actinium-225 through its subsequent daughters.   
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1.2.2  Inorganic Radiochemistry  
The applications of radioelements fall into two categories, organic chemistry and 
inorganic chemistry. Radiochemistry with nonmetals (i.e. C-11) usually involves substituting one 
element in a molecule for a radioactive isotope of the same element. Radiometal chemistry 
involves manipulating radioactive metals, which may or may not be redox active, and 
incorporating them into complexes. This study focuses entirely on inorganic radiochemistry, the 
oxidation/reduction, separation, and chelation of radiometals.  
1.3 Actinium  
Actinium, specifically 225Ac, is a promising radiometal for the treatment of disease. This 
is because not only can 225Ac itself be used for the treatment of cancer,3-7 but a daughter of 225Ac 
(213Bi) can also be used to treat cancer and potentially kill the HIV virus.6-7, 17 
The discovery of actinium is credited to Andre-Louis Debierne and Friederich Oskar 
Giesel.18 In 1899, Debierne reported a new radioactive metal from leftover pitchblende (mined 
uranium ore) from Marie and Pierre Curie’s work. In his work, he reported on an element that 
was distinct from other elements found in that ore like polonium and radium. Unfortunately, 
Debierne’s reports of the behavior of actinium were conflicting and his papers lacked specific 
experimental details. In 1899,19 he stated that the properties of actinium were similar to titanium 
and in 1900 he asserted the properties were similar to thorium.20 Also, in the first actinium paper, 
he claimed that actinium was isolated in a “rather complicated procedure that will be explained 
at a later time”, yet this procedure was never explained in that paper or any of his following 
papers. It is impossible to determine if he actually discovered actinium, a mixture of metals, or 
another element that would not be discovered for another 14 years, protactinium. In 1904, a 
German chemist, Friederich Oskar Giesel, discovered an element similar to lanthanum using a 
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zinc sulfide screen. 21 This element was carefully isolated through an ammonia precipitation 
following an oxalic acid separation. Giesel reported that the chemistry of this new element was 
found to follow the chemistry of the earth metals (La, Ce, etc). Giesel suspected that he had 
discovered a new element but delayed choosing a name until what he isolated could be compared 
to what was isolated by Debierne. Eventually, Giesel was able to compare his isolated material to 
Debierne’s. Much to his dismay, his material behaved very similarly to what Debierne had 
isolated. Debierne never disclosed exactly how he had discovered the actinium in his first paper 
and Giesel was only allowed to compare his material to what Debierne isolated 5 years after his 
original paper. It is impossible to know for certain whether or not there was any actinium present 
in Debierne’s original sample but since he was the first to claim it, the credit for the discovery of 
actinium was given to him.	
Actinium has no known stable isotopes. The isotope of interest for this study and for 
targeted alpha therapy is 225Ac, which has a half-life of 10 days. 225Ac decays via alpha emission 
of 5.8 MeV and has four alpha emitting nuclides in its decay chain (221Fr, 217At, 213Bi, and 213Po) 
(see Figure 1.6) which makes it a potential in vivo generator of alpha emitting nuclides.22 
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Figure 1.6. 225Ac decay chain.			
The challenge for working with alpha emitters is that they are toxic, and the Nuclear 
Regulatory Commission (NRC) limits for alpha contamination are strict. The limit for allowable 
removable contamination for alpha emitters is 50 times lower than that of beta emitters. Alpha 
particles can easily be shielded by glass or even a sheet of paper, and they cannot penetrate the 
skin, so alpha emitters pose no risk to the body as an external source. However, if an alpha 
emitting nuclide was to enter the body, there is a chance for developing cancer, degenerative 
changes, teratogenesis, and other disorders.7 These restrictions limit where alpha emitters are 
handled and requires extreme diligence when handling these isotopes. 
Actinium usually exists as a 3+ ion that has no electrons in its outermost shell (5f0 6d0). 
This configuration makes actinium invisible to many forms of spectroscopy and makes 
characterization difficult.23 This obviously limits the means by which actinium can be studied. 
Actinium-225 is radioactive and can therefore be detected but, 225Ac itself cannot be identified 
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with gamma spectroscopy as it does not emit a gamma ray detectable by this method. The 
daughters of 221Fr and 213Bi are used to identify 225Ac for separation studies. In order to detect the 
presence of 225Ac in a solution, the solution must sit and decay until secular equilibrium is 
reached so that the daughters grow in and can be observed.   
The majority of 225Ac comes from thorium-229 generators. The global supply of 225Ac 
from 229Th generators is on the scale of 1.7 curies per year, while the global demand is 50-100 
curies per year.8 Radionuclide generators are columns to which the parent nuclide is bound and 
from which the target nuclide can be separated. In the 229Th/225Ac generator,24-26 229Th is bound 
to an anion exchange resin using high concentrations of nitric acid. Over time, 229Th decays to 
225Ac, which is eluted or “milked” from the column using 8 M nitric acid. This method has two 
issues: 1) There is a finite supply of 229Th as it is a waste product of 233U and 2) 229Th has a 
relatively long half-life of 7800 years. It decays to 225Ra which then decays to 225Ac. In order to 
obtain the highest yield (~100 mCi) with the highest radiochemical purity (>96%) the generator 
is milked every 60 days. 
225Ac can also be produced using cyclotrons and linear accelerators. Cyclotrons are 
particle accelerators which accelerate charged particles in a spiral pattern to hit a target and 
produce isotopes. Actinium-225 can be produced from radium-226 using a cyclotron. This 
method seems to produce very pure 225Ac 27-28 but in small quantities. Linear accelerator 
production can yield one thousand-fold the amount of Ac produced by a cyclotron using 
naturally occurring 232Th. The higher bombardment energies in a linear accelerator produce large 
quantities of 225Ac but also yield hundreds of other isotopes.9, 28-29 
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It is imperative to increase the amount of 225Ac available for research and clinical trials.  
A study found that 225Ac can be used to treat metastatic prostate cancer tumors.1 In this work, a 
patient with metastatic prostate cancer tumors was first treated with of prostate specific 
membrane antigen (PSMA) labeled with 177Lu (beta emitter). The tumors did not decrease in 
size. 225Ac-PSMA was then employed and after three rounds of treatment all visible lesions from 
the disease had been removed. Figure 1.7 shows the 68Ga PET scan of the patient after three 
rounds of 225Ac-PSMA treatment. While this study was important and impactful, there are far 
more studies with 225Ac which need to be conducted. The limited supply of 225Ac severely limits 
the progress of the development of 225Ac therapeutic agents.  
	
 
Figure 1.7.  68Ga-PSMA-11 PET/CT scans of patient A  
 
 
Pretherapeutic tumor spread (A), restaging 2 mo after third cycle of 225Ac-PSMA-617 (B), and 
restaging 2 mo after one additional consolidation therapy (C).1 This research was originally 
published in JNM. Kratochwil et al 225Ac-PSMA-617 for PSMA targeted alpha radiation therapy of 
metastatic castration-resistant prostate cancer. J Nucl Med. 2016;57:1941-1944. © SNMMI 
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The daughters of 225Ac can also be used for the treatment of disease. 
Radioimmunotherapy with 213Bi has been used to treat the HIV virus. In this study, 
immunocompromised mice were infected with the HIV virus and treated with antibodies labeled 
with 213Bi (alpha emitter) and 188Re (beta and gamma emitter). The mice treated with 213Bi had 
the largest decrease in the number of HIV infected cells.17 This is very important work and far 
more tests need to be conducted. These tests cannot continue if the parent nuclide of 213Bi is in 
short supply.  
1.4 Thorium  
While typically used in nuclear energy,30-31 thorium also has potential applications in 
nuclear medicine. Isotopes of thorium can be used to produce 225Ac. For example 232Th can be 
used as a target for the spallation reaction 232Th (p,x) 225Ac and 229Th is used as a generator for 
225Ac. Also, 227Th can be isolated from 227Ac and used in targeted alpha therapy (TAT).   
The first report of thorium was a case of mistaken identity. Yttrium orthophosphate was 
isolated and incorrectly identified as a new element in 1815 by Swedish chemist Jōns Jacob 
Berzelius. This new element was named Thorium after the Norse god of thunder, Thor, however, 
once it was discovered that the mineral isolated was actually an yttrium complex and not a new 
element, those findings were retracted. Seventeen years later, Berzelius received a mineral rock 
which contained an undiscovered element, Berzelius repurposed the name Thorium for this 
element. The mineral was actually a thorium oxide, which was dubbed thorite.32 
The isotopes of interest for this work are 232Th as the spallation target for actinium-225 
production and 227Th as a potential targeted alpha therapy agent. 232Th has a half-life of 1.4×1010 
years, decays via alpha emission (4.01 MeV) to 228Ra and is a part of the 235U decay chain 
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(Figure 1.8). 227Th decays via alpha emission of 223Ra (6.04MeV) and has a half-life of 18.7 
days.  
	
 
Figure 1.8. 235U decay chain.  
 Source: Edgar Bonet "https://creativecommons.org/licenses/by-sa/3.0">CC BY-SA 3.0 
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Thorium usually exists as a 4+ ion and is largely redox inactive, meaning that it has a 
very high standard reduction potential.33-34 This oxophilic metal has complicated coordination 
chemistry where at higher pH (>7) thorium precipitates out of solution in the form of various 
water insoluble oxides. While thorium generally only exists as the 4+ ion, it can have 
coordination numbers from 4-15, the most common coordination number being 8.  
Much of the thorium isolated from the earth is 232Th. The abundance of 232Th is 6,000 
ppb which is three times higher than the abundance of 238U. 232Th that is mined is used as fertile 
material in a nuclear reactor.31 232Th captures a neutron to become 233Th which decays to 233Pa 
which decays to 233U. The use of thorium in a reactor reduces the risk of weapon proliferation. 
The concern is that in a 235U/238U reactor, 239Pu is generated from the absorption of neutrons. The 
produced plutonium can be isolated and potentially used for weapons. When thorium fuel is used 
in reactors plutonium is neither used nor generated.  
There is also potential for the use of 227Th (half-life= 18.7 days) for targeted alpha 
therapy. It has a longer half-life 225Ac (half-life= 10.0 days) and may be more useful for killing 
tumor cells at different stages of development when cells have different sensitivities to radiation. 
Thorium also has similar chemistry to zirconium, so the chelators used to coordinate zirconium 
(4+, 8 coordinate) may also chelate thorium. 89Zr has been used in positron emission tomography 
(PET) imaging agents and when combined with 227Th has the potential to be used as a theranostic 
pair, meaning that 89Zr serves as a diagnostic tool with PET imaging and 227Th can be used as the 
therapeutic agent. 
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1.5 Technetium 
Technetium-99 is a high-yield fission product of 235U and 239Pu. 99Tc has a long half-life, 
complex coordination chemistry and is a large contributor to the radiation dose from nuclear 
waste. 
In 1869, Mendeleev predicted an element with 43 protons which would be between 
molybdenum and rhenium on the periodic table. He was correct in this prediction but the element 
would not be discovered for another 70 years. In 1937, technetium was discovered by Emilio 
Serge from a soon-to-be-discarded molybdenum foil from a cyclotron that had become 
radioactive after bombardment with deuterons. From this foil, the metastable state of 95Tc 
(95mTc) was isolated and officially discovered.35 
Technetium has no known stable isotopes. The isotopes of interest of technetium are 
99mTc and 99Tc. The most commonly used isotope, 99mTc, has a 6-hour half-life and decays via 
gamma emission (140.5 keV) to 99Tc. It is used clinically for medical imaging. The most 
abundant isotope is 99Tc, which decays via beta emission (beta max 297 keV) to Ru-99. 99Tc has 
a half-life of 213,000 years. Similar to actinium, technetium contamination can spread on its 
own. 
Technetium is a transition metal with 7 electrons in the valence shell of its neutral state. 
Like its counterparts in group 7, technetium commonly exists as the XO4- ion where X is the 
metal, This Tc species is called pertechnetate (TcO4-). While its position is in the center of the 
group, its behavior is more similar to rhenium than manganese. Technetium is less reactive than 
manganese, which is often used as an oxidizing agent in organic chemistry reactions, and only 
slightly more reactive than rhenium, which is used in catalysis. Technetium is a redox-active 
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metal with a wide range of oxidation states (-1 to +7) its most common oxidation states being +7, 
+5, +4, and +1.   
In the 1940’s and 1950’s, the United States produced large amounts of plutonium-239 
and uranium-235 for nuclear weapons. The radioactive legacy waste from these activities is kept 
in underground storage tanks at Hanford and other waste sites in carbon steel tanks encased in 
concrete to decay.13 Hanford alone has 177 carbon steel tanks holding a total of ~26,500 Ci of 
99Tc.13  The storage method was supposed to be a temporary solution to the waste problem as the 
tanks were only supposed to last for 20 years. After nearly 80 years it should come as no surprise 
that the tanks are leaking radioactive materials into the ground and subsequently the ground 
water. A significant portion of that waste is 99Tc, however, the chemistry of technetium within 
the tanks is not well understood. While there are likely a variety of technetium species in the 
tanks in various oxidation state, the most common are expected to be the pertechnetate ion 
(TcVIIO4-) and some Tc(I) carbonyl species. 
High concentrations of a non-pertechnetate species identified to be [Tc(CO)3]+ was also 
found in Hanford tank waste. The formation of the carbonyl was attributed to the reduction of 
TcO4- in presence of organic ligands (e.g. formate, EDTA, NTA) and scavenging the O- radical 
produced during radiolysis. Additionally, tanks containing high concentrations of organic 
ligands, L, (e.g. citrate, oxalate) increased the stability of Tc(CO)3L3 complexes, demonstrating 
that [Tc(CO)3]+ is able to form complexes with organic ligands. Further characterization of 
[Tc(CO)3]+ in the Hanford tanks has become a priority.13 In some Hanford waste tanks, even 
under exposure to atmospheric oxygen, more than 50% of 99Tc is in the form of soluble, low 
valent 99Tc that cannot be removed by ion exchange and is difficult to oxidize.36-37 x-ray 
absorption spectroscopy (XAS) studies suggest that the species is possibly TcI(CO)3•(gluconate). 
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Having different species in one solution complicates storage strategies as the two complexes 
exhibit different chemical behaviors.   
One strategy for dealing with the tank is vitrification, which is trapping the waste in 
borosilicate glass. Simulated tank waste was used in test runs to determine efficiency of 
vitrification. Unfortunately, up to 80% of the Tc was volatilized using this method. The volatile 
Tc is captured and recycled into the melter where the vitrification is taking place, thus increasing 
the yield from 35% to 76% on average. It has been theorized that the low yield and 
volatilizations are due to the formation of pertechnic acid (HTcO4) or ditechnetium heptoxide 
(Tc2O7) from pertechnetate (TcO4-) which are both neutral volatile compounds.14  
1.6 Summary 
This body of work seeks to address real world problems such as the actinium-225 
shortage, identifying appropriate isotopes for targeted alpha therapy, and the nuclear waste 
storage problem at legacy sites using basic principles of coordination and redox chemistry. In 
chapter 2, we are exploiting the coordination chemistry of Th4+ using polyoxometalates (POM) 
that possess well-defined donor atoms positioned to create highly stable Th POM complexes. 
The stable Th POM complexation drives the extraction and allows separation of Th from 225Ac. 
Chapter 3 also utilizes the coordination requirements and the oxophilicity of Th4+ to identify 
suitable ligands to form stable complexes for potential use in Targeted Alpha Therapy using 
227Th. The radioactive decay of 227Th presents real challenges in designing strategies for reducing 
dosage in clinical studies and for enhancing radiolabeling yield.  Chapters 4 and 5 discuss 
Technetium-99 investigations where the extensive redox chemistry is a main point of interest and 
a common thread running through both chapters.  
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All the metals studied in this thesis are radioactive; in fact, these radioactive metals emit 
long-lived beta particles (e.g. 99Tc) and alpha particles (e.g. 225Ac and 227Th).  These are some of 
the most difficult radioisotopes to handle and analyze. However, the special instruments used for 
analysis enable us to identify and quantify these elements and their compounds on a much 
smaller scale than what would normally be needed for standard methods of spectroscopy. 
Understanding the fundamental chemistry of actinium, thorium, and technetium are vital to 
developing methods for extracting, purifying, developing new medical constructs for therapy and 
for long term storage of these metals. These studies offer a new perspective on these issues and 
may open other avenues of research.  
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2.  The Separation of Actinium from Bulk Thorium 
using Wells Dawson Polyoxometalates (P2W18O62) 
2.1 Introduction 
Actinium-225 (t1/2: 9.92 d) is an alpha emitting radionuclide that has great potential for 
targeted alpha therapy treatment for cancerous tumors. Along with the emitted 5.83 MeV alpha 
particle, 225Ac also results in an additional 3-4 alpha particles in its decay chain. The low 
penetration range (50-90 µm) and high linear energy transfer of α particles allows for maximum 
malignant cell destruction with minimal toxicity to non-target tissues. 
Presently, the main source of 225Ac for pre-clinical and clinical studies is the 229Th 
generator decaying to 225Ac. 229Th and other daughters of 233U such as 225Ra and 225Ac are 
separated using a large anion exchange column and nitric acid. Once separated, thorium is loaded 
onto a smaller column using 8 M nitric acid and is left to decay first to 225Ra and then to 225Ac. 
The daughters are eluted with 8 M nitric acid. 225Ac is separated from Ra- in a similar fashion 
using UTVEA ® resin (Eichrom) and 4 M nitric acid. At 4 M nitric acid, actinium is bound to 
the resin which is especially designed to bind actinides. Radium does not bind to the column and 
is eluted from the column. Actinium is then eluted from the column with 0.05 M nitric acid.38 
The half-lives of these isotopes are 7,880 years, 14.9 days, and 10 days respectively. The optimal 
elution time for the generator is reached at four times the half-life of the daughter. This is the 
point where the activity is near its maximum, and any further increase in activity over time does 
not contribute significantly to the total activity. The optimal elution time for a 229Th generator 
will be reached in 60 days. This is the limiting factor of the production of 225Ac from a generator. 
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Fortunately, 225Ac can be produced via proton irradiation of thorium metal. In this 
strategy, a thorium metal target is bombarded by high energy protons prompting the spallation 
reaction 232Th (p,x) 225Ac. During a week-long irradiation this process will theoretically produce 
Curie levels of 225Ac along with many other radionuclides. A partnership between Brookhaven 
(BNL), Los Alamos National Laboratory (LANL), and Oak Ridge National Laboratory (ORNL) 
is working to produce 225Ac to meet the demands of the medical community. The “Tri-Lab R&D 
effort” will utilize the Brookhaven Linear Isotope Producer, the Isotope Production Facility 
(LANL), and the ORNL processing facility to produce curie amounts of 225Ac. There are three 
phases to the project, which is currently in phase 2. Phase 1 was proving the feasibility of 
making 225Ac from 10 g thorium targets. Phase 2 will focus on scaling up the irradiation to 100 g 
targets, and phase 3 will focus on the distribution of 225Ac to hospitals and research facilities.  
The separation of 225Ac from small thorium targets (1-10 g) and other produced 
radionuclides to produce 225Ac for pre-clinical and clinical studies involves running five different 
columns and takes over three days. Due to the long processing time and waste generation, this 
approach is untenable for thorium targets of 100 – 400 grams. Efficient and scaled up separation 
of the 225Ac from the bulk thorium matrix as well as from the highly radioactive activation by-
products, especially radiolanthanides, formed from proton-induced spallation are needed and are 
addressed by this project.8-12, 26, 29, 39-43 
The current project employs polyoxometalates (POMs), as a proof of concept, to identify 
materials that will bind either Th4+ (or Ac3+) for separations. We hypothesized that the selected 
POMs with basic defect sites would form highly stable complexes with Th4+ and other +4 metal 
ions for separation of bulk thorium from 225Ac. Also, POMs may serve to purify 225Ac from 
lanthanide and other radionuclidic by-products.  
 25 
2.1.1 Background 
2.1.2 Polyoxometalates  
Polyoxometalates or POMs are polyanionic aggregates of early transition metal oxides 
which have the standard formula of [XXMMOP]n. Where “X” represents the heteroatom, “M” 
represents the main metal at its highest valence and “O” is oxygen. The main metal can be 
molybdenum, vanadium, tungsten, etc. and the heteroatom can be phosphorus or silicon. In this 
work, the POMs are exclusively synthesized with tungsten as the main metal and phosphorous as 
the heteroatom. MO6 octahedra are condensed to form aggregates primarily by sharing oxygen 
atoms in a µ-dioxo linkage at corners and in di-µ-oxo linkages at the edges of the polyhedra.  
When incorporated into the POM structure, the main metals are at their highest oxidation 
state. A fully oxidized metal does not contain d electrons and can form strong bonds with π 
donor atoms such as oxygen. The oxygen atoms donate electrons to the empty orbitals of metals 
thus creating a framework of strong metal oxide bonds. The “plenary” POMs (such as the Wells-
Dawson ion, (P2W18O62)6- can essentially be viewed as 2 PO43- units surrounded by a (WO3)18 
neutral cage and thus are quite unreactive towards cations despite an overall charge of 6-. POMs 
can be modified by removal of a W=O unit to create a vacancy that can coordinate additional 
metals. With one unit removed, the modified POM can serve as a hard ligand through its 
vacancy. There are many structural types of POM; this study will focus on the Wells Dawson 
(WD) structure.  
The Wells-Dawson POM has the formulation of (P2W18O62)6- and the intact POM is 
referred to as the plenary POM. The modified POM with the vacancy is referred to as the 
lacunary POM. The modified Wells-Dawson can have two confirmations, (a1-P2W17O61)10- and 
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(a2-P2W17O61)10- (a1-WD, a2-WD, respectively). a1 has the vacancy in the center or “belt” of the 
molecule and a2 contains the vacancy in the top or cap of the molecule (Figure 2.1). The two 
isomers of the POM have different properties that affect their binding strengths and redox 
properties. For example, the a1 isomer has a larger and less flexible vacancy (3.7 Å) then the a2-
isomer (3.4 Å). While they have very different structures and behaviors both isomers of the 
Wells Dawson POM prefer hard cations for coordination due to the oxygen donors.  
 
Figure 2.1. Polyoxometalates used in this study  
 
2.1.3 Polyoxometalates, Lanthanides and Actinides  
There are many types of POMs that can bind actinides, lanthanides, and Th(IV) 
specifically44-51(Gregory R. Choppin, 2002; Copping et al., 2008; Duval et al., 2015; Humelnicu 
et al., 2008; Humelnicu et al., 2009; Li, Wang, & Xu, 1996; Nikiforov, Nichkova, & Pushkarev, 
1983a, 1983b)43-5043-50. This study will focus on the Wells-Dawson POM and its isomers because 
it has been shown that these POMs show large differentials in their stability constants with 
lanthanides and Th4+ as a function of ionic radius and charge/size ratio.52 We hypothesize that 
Left: the Wells-Dawson ion, (P2W18O62)6-, middle: (a2-P2W17O61)10- with the vacancy in the “cap” region, right: 
(a1-P2W17O61)10- with the vacancy in the “belt” region. W atoms are colored dark blue; oxygen atoms are colored 
red with oxygen atoms in the vacancy colored light blue 
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this can be translated to large separation factors for separation of Th4+ from Ac3+ as well as the 
+3 lanthanides and +2 ions present in solution after irradiation of thorium targets. Choppin and 
Wall have shown that Th4+ forms highly stable a2-WD complexes of the 1:2 Th: a2-WD 
stoichiometry with stability constants on the order of log β2= 40.51,53 We and others have shown 
that lanthanides form highly stable 1:1 and 1:2 Ln: a2 -WD and Ln: a1 -WD complexes with log 
β2 on the order of 15-18. The order of magnitude difference in stability constants between Th4+ 
and Lanthanides+3 bodes very well for achieving high separation factors between Th4+ and Ac3+ 
ions. We hypothesize that this significant difference in stability will allow extremely efficient, 
thorough, and fast separation of thorium from 225Ac. Another motivation for this study is that one 
of the POMs employed, (a2-P2W17O61)10-, exhibited significantly high extraction of 177Lu over 
153Sm.52 Here we employ similar conditions to that study; however, we scaled up and also 
employ both individual metals and mixed metals in the extractions.  
Additionally, unlike organic extractants, POMs are radiation resistant.54 In fact, when 
irradiated with gamma radiation, the a2 -WD - experienced reduction but maintained it structural 
integrity. Since the reduced a2 -WD - can be readily oxidized, this may be an ideal extractant in 
high radiation fields. Some POMs, similar to those used in this study, are also commercially 
available because they are used in bulk catalyst processes  
2.2 Experimental:  
2.2.1 Methods and Materials 
General Considerations for handling alpha emitters 
232Th, 225Ac, and 227Th are a emitters of various energies All syntheses and handling of 
solutions were conducted in a laboratory approved for manipulation of alpha emitting 
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radionuclides with certified HEPA filtered fume hoods and monitored with α, β, and γ detecting 
instruments.  
2.2.1.2 Commercial Reagents 
Cerium and rhodium metal solutions were prepared from SpexCertiprep ICP standards 
(1000 ppm). Thorium-232 nitrate and nitric acid were obtained from Thermo Fisher Scientific. 
Lanthanum nitrate, octylamine, chloroform, and all other reagents were purchased from Sigma. 
Both 227Th and 225Ac were obtained from Oak Ridge National Laboratory through the United 
States Department of Energy Office of Science Isotope Program in the Office of Nuclear Physics 
Deionized water (18 MΩ) was obtained from a 0.22 µm Millipore water system.  
2.2.1.3 Polyoxometalates  
Plenary-POM (a-P2W18O62)6- was synthesized by the Francesconi lab using the Contant55 
method. The procedure is as follows: Sodium tungstate is dissolved in water and concentrated 
phosphoric acid is added to the solution, which is then heated under reflux for 4 hours. After 
cooling, ammonium chloride is added to the solution to precipitate the POM. The crude POM is 
then recrystallized from water. In this synthesis, are two isomers of the Wells-Dawson ion, (a-
P2W18O62)6-(14 H2O), and (b-P2W18O62)6-(19H2O), and the Preyssler ion, K14NaP5W30O110,  are 
synthesized. These isomers are manually separated using fine forceps  
a2- WD (a2-P2W17O61)10- was synthesized by the Francesconi lab using the Contant55 method.  
The procedure goes as follows: the plenary POM (P2W18O62) was dissolved in water and a 
solution of KHCO3 was added while stirring. After 1 hour, a white precipitate formed and was 
separated from the mother liquor via vacuum filtration. The precipitate was then recrystallized 
from water. The structure of the POM was confirmed using 31P NMR. 
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a1-WD (a1-P2W17O61)10- was prepared by the Burton-Pye lab using the Contant55 method. The 
procedure goes as follows: lithium chloride was dissolved in water and the plenary POM 
(P2W18O62) was added to the solution while stirring. Lithium tungstate was added to the solution. 
1 M HCl was then added dropwise to the solution while the pH of the solution was kept between 
4 and 5. A saturated KCl solution was then added and a white solid precipitated immediately. 
The white solid was isolated, washed with ethanol, and dried under vacuum. The structure of the 
POM was confirmed using 31P NMR. 
POM solution standardization was performed using a method found previously used by the 
Francesconi group.56 Both alpha 1 and alpha 2 are precipitated with other salts during the 
synthesis. Therefore, the calculated concentration of the solution is not the true concentration of 
the solution. To correct this, a UV-VIS titration of the POM solutions is done using cobalt 
chloride. Co2+ can coordinate to the POM in a 1:1 ratio, the absorbance of cobalt-POM species 
can be observed at 544 nm. For the POM titration, the spectrometer is set to 544 nm and the 
aqueous solution of the POM is used as the blank. The cobalt solution is added to the POM 
solution 5 µl at a time and the absorbance is measured each time. The absorbance increases 
linearly until the ratio of cobalt to POM is 1:1. At that point, the absorbance “breaks away” from 
its linear trend and remains the same. 
2.2.2 Instrumentation:  
2.2.2.1 Inductively Coupled Plasma Optical Emission Spectroscopy (ICP OES) 
All ICP measurements were carried out on a Perkin Elmer Optima 7300 Dv Optical 
Emission Spectrometer. Inductively Coupled Plasma Optical Emission Spectroscopy is an 
analytical tool which enables the user to detect elements at low concentrations. An aqueous 
solution runs through a nebulizer to be converted into a fine mist which is then drawn into a 
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plasma. The plasma, which is generated by argon gas, is very hot, up to 10,000 K. At this 
temperature, the mist of the sample atomizes and the elements become excited from the thermal 
energy of the plasma. Each element has its own characteristic emission wavelength. The 
wavelengths and their intensities are used to quantify the elements in the sample by converting 
the intensities to concentrations. 
Calibration curves are routinely performed on the ICP to ensure it is working properly. 
Standards of the desired elements are used to generate a calibration curve; the standard is a 10 
ppm mixed metal solution which is diluted to the concentrations required for the calibration 
curve. The solutions are then run on the machine and the reported concentrations are compared 
to the theoretical concentration. If the measured concentration is exactly the same as the 
expected concentration, the curve is given a value of 1. There will always be slight differences 
between the two values, therefore a calibration curve value of 0.999 is acceptable. 
2.2.2.2 Gamma Spectroscopy 
All gamma spectroscopy measurements were carried out on an ORTEC GEM series 
HPGe (High-Purity Germanium) Coaxial detector system. Gamma ray spectroscopy is a form of 
solid-state radiation detection, which utilizes a semiconductor to detect gamma radiation. The 
semiconductor absorbs the energy from the emitted gamma ray and undergoes different 
mechanisms depending on the energy of the particle emitted. The interaction of the semi-
conductive material with the incident gamma ray causes the formation of an electron-hole 
charged pair which moves through the material and generates a signal. The gamma spectrometer 
is routinely calibrated using a standard with a mixture of isotopes with distinct energies and 
known activities.  
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Metal solution standardization: All metal solution concentrations were determined by ICP.   
2.2.3 Extractions  
2.2.3.1 Solutions 
The procedure to prepare extraction solutions is modified and scaled up from our 
previous study.52 The aqueous solutions were prepared by creating a solution of nitric acid and 
potassium acetate to make a 0.5 M nitric acid solution (pH=1), adding an aliquot from the 
standardized metal solution (45-90 µl), varying amounts of the standardized POM solution to 
vary the ratio between the metal and the POM (61µl-610µl), and enough DI water to make a 15 
ml solution. Reagents were added in rapid succession in the order listed below. The organic 
solution was 3% octylamine in chloroform (v/v). Both the aqueous solution and organic solution 
were prepared immediately before each experiment.  
 
 
Table 2.1 Aqueous solution for extraction studies 
Ratio 
Metal:POM 
1:1 1:3 1:5 1:7 1:10 
5 M HNO3 1.5 ml 1.5 ml 1.5 ml 1.5 ml 1.5 ml 
H2O ~13 ml ~13 ml ~13 ml ~13 ml ~13 ml 
0.2 M KOAc 0.060 ml 0.180 ml 0.300 ml 0.420 ml 0.600 ml 
8.7 mM POM 0.061 ml 0.183 ml 0.305 ml 0.427 ml 0.610 ml 
1000 ppm Metal ~0.068 ml ~0.068 ml ~0.068 ml ~0.068 ml ~0.068 ml 
Final 15 ml 15ml 15 ml 15 ml 15 ml 
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2.2.3.2	Extraction	procedure	
The aqueous and organic phases were combined in a 1:2 ratio; the experiments were 
completed in triplicate where 4 mL of the aqueous solution was added to glass vials, and the 
remaining 3 ml was used as the stock solution for analysis. 8 ml of the organic solution was also 
added to each vial. The vials were then agitated using a Compact digital waving rotator 
(ThermoFisher Scientific) for up to 12 hours in order to reach equilibrium. The mixture was 
allowed to separate for 48 hours and the aqueous phase was removed for analysis. After the 
phases separate the top layer (aqueous) was removed by decantation with a pipette and diluted 
for ICP studies (see below). The organic layer was measured using gamma spectroscopy for the 
227Th and 225Ac studies.  
2.2.3.3 ICP Nebulizers 
There are two kinds of nebulizers available for the Perkin Elmer ICP, one is made of 
glass and has a narrow opening, the other is made of plastic and has a wider opening. For the 
extraction studies using the POM; we found that the best tungsten ICP data, where the 
concentrations were close to the calculated ones and with low errors, were obtained with the 
plastic nebulizer with a sample flow rate 2 ml/min and a gas rate of 0.8 ml/ min.  
2.2.4 Preparation of Solutions for ICP  
ICP samples were prepared by diluting a 1 ml aliquot of the aqueous phase 10 times, in 
2% nitric acid, to result in a concentration of 1 ppm of the added metal ions to be analyzed. To 
ensure optimal operation scandium was used as the internal standard, permitting the 
simultaneous measurement of the internal standard and the sample.  
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2.3 Results: 
2.3.1 Extraction of Polyoxometalate only– monitoring  
In order to understand the mechanism of extraction, the extraction of each individual 
component must be examined. The POM extraction is monitored by the presence, or lack of 
tungsten in the aqueous layer. In all of the extractions, the POM is almost completely removed 
from the aqueous solution.  
2.3.2 Individual Metal Extraction 
The extraction behavior of individual metals with both isomers of the POM in a 1:1 metal 
to POM ratio were studied as shown in table 2.2. Thorium demonstrates a high affinity for both 
isomers of the POM, this is exhibited by the virtually complete extraction of thorium from the 
aqueous solutions into the organic solutions (>98%). Lanthanum experienced about 40% 
extraction, verifying the less avid binding of La3+ compared to Th4+ for both POMs. La3+ is 
commonly used as a surrogate for Ac3+. In the cerium samples, the metal exists in both the +3 
and +4 oxidation states. Therefore, the cerium extraction is expected to behave like the +3 ions 
as well as the +4 ions. Cerium is extracted 44% and 33% with a2-WD and a1-WD respectively. 
Rh3+ is a soft metal ion and does not have high affinity for the “hard” oxygen binding sites of the 
POMs. Also, Rh3+ is a kinetically inert ion. Taken together, these two facts likely prohibit the 
Rh3+ binding into the POM cavity and is shown by the ~5% extraction in the figure. The small 
rhodium extraction is likely due to an electrostatic interaction between the anionic POM and the 
cationic metal via a cation exchange with the potassium of the POM.  
2.3.3 POM Extraction 
Table 2.3 shows the extraction of the tungsten in the presence of the individual metals 
extractions shown in table 2.2. Upon looking at the extraction of the POM without any metals, it 
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is clear that the extraction is independent of the metals in solution. The POM is consistently 
extracted despite the presence of metals in solution. For example, during the study of rhodium 
extraction, there is very little rhodium (~5%) extracted into the organic solution (table 2.2). In 
that same study, nearly 100% of the POM is extracted (table 2.3). The POM is extracted with 
approximately the same concentration despite the other metal that being extracted.  
Table 2.2. Extractions of individual metals into the organic phase. The metals are Ce3+/4+, Rh3+, La3+, and Th4+ 
POM Thorium Lanthanum Cerium Rhodium 
a1-WD 97±0.4 40±0.5 33±1.6 12±3.5 
a2-WD 98±0 43±5.4 44±5.1 2.8±2.6 
 
Table 2.3. POM Extraction into the organic phase from the single metal study shown in table 2.2 
 POM 
Metal from table 2.2 a1-WD a2-WD 
Thorium 100±0.1 100±0.14 
Lanthanum  99±0.14 100±0.33 
Cerium 99±0.2 100±0.1 
Rhodium 100±0.2 100±0.2 
 
2.3.4 Extraction of mixed metals including Th and La 
Lanthanum is commonly used as a cold (non-radioactive) surrogate for actinium. In this 
experiment, thorium and lanthanum were combined at a 1:1 Th:La ratio while varying the 
stoichiometry of the a2-WD and a1-WD in the extraction experiments. The extraction data is 
shown in table 2.4. For both POMs, at 1:1:1 Th:La:POM stoichiometries, Th4+ is almost 
completely and exclusively extracted (97%) while all the La3+ remains in the aqueous layer (0% 
extraction). Varying the concentration of POM (1:1:3 Th:La:POM), Th4+ is extracted greater 
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than 98% while lanthanum is extracted close to 50%. This is to be expected because the 
stoichiometry of POM is larger than that of both thorium and lanthanum and allows for the 
partial extraction of La3+. At 1:1:5 Th:La:POM stoichiometry, all thorium and lanthanum are 
extracted. As expected, at higher POM stoichiometries, i.e.  1:1:7 and 1:1:10 Th:La:POM, all 
thorium and lanthanum are extracted 
Table 2.4 Extractions of mixed metal, thorium and lanthanum solutions 
a1-WD Thorium Lanthanum 
Th:La:POM 1:1:1 97±0.3 0±0.8 
Th:La:POM 1:1:3 100±0 48±1.6 
Th:La:POM 1:1:5 100±0 100±0 
Th:La:POM 1:1:7 100±0 100±0 
Th:La:POM 1:1:10 100±0.1 100±0.05 
a2-WD Thorium Lanthanum 
Th:La:POM 1:1:1 98±0.06 0±1.0 
Th:La:POM 1:1:3 100±0 60±1.2 
Th:La:POM 1:1:5 100±0 100±0 
Th:La:POM 1:1:7 100±0.11 100±0.11 
Th:La:POM 1:1:10 100±0.0 100±0.10 
 Table 2.4 shows extractions of mixed metal, thorium and lanthanum solutions with a1-WD (Top) and a2-WD 
(Bottom) as a function of POM stoichiometry.  Each experiment represents 1:1:x : Th:La:POM 
(x=1,3,5,7,10) and either a1-WD or a2-WD. 
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2.3.5 Extraction of 227Th 
The extraction of 227Th was carried out to confirm the extraction of thorium into the 
organic layer. All previous extractions were studied by performing ICP on the aqueous layer 
because non-radioactive metals were used, therefore the extraction of the metal-POM complex 
into the organic layer can only be measured indirectly. The aqueous layers showed little thorium 
content. This experiment confirms that thorium is not adsorbed to the glass vials or in some other 
way removed from the aqueous layer. 227Th possesses a gamma energy that can be detected 
easily using gamma spectroscopy (236 keV) which allows for the direct measurement of the 
extraction of thorium into the organic layer. In this experiment, 232Th is “spiked” with 10% 227Th 
with a ratio of 0.1:1:1 227Th:232Th:a2-WD POM the extraction was quantified using both ICP 
(aqueous layer) and HPGe (organic layer). Both methods show that thorium is nearly completely 
extracted (98%) into the organic layer. (Table 2.5) 
Table 2.5. 227Th/232Th extraction quantified with HPGe and ICP 
Method of quantification: % Extraction 
HPGe 100±0 
ICP 98±0.13 
 
2.3.6 Extraction of 225Ac individually and in combination with other metals 
The separation of actinium as a single metal as well as in a mixed metal solution was 
examined to determine its selectivity with the POM (see table 2.6). In these experiments, either 
as an individual metal or in combination with other metals, 225Ac was studied using quantities 
which simulate the concentrations of 225Ac found in target samples. The ratio of 225Ac to POM in 
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the single metal and mixed metal extractions was 0.1:1. For the 225Ac extraction, both the organic 
and aqueous layers were counted for 225Ac using the HPGe detector after secular equilibrium was 
reached, monitoring the 413 keV energy peak of the daughter 213Bi. As an individual metal, there 
is significant extraction of 225Ac into the organic layer observed with both isomers a1-WD 
(73.3%) and a2-WD (82.8%). This is to be expected as the POMs can extract 3+ metals. 
However, the extraction of 225Ac in the presence of thorium (0.1:1:1 Ac:Th:POM) decreases 
dramatically to a1-WD (3.0%) and a2-WD (11 %). Similarly, if lanthanum is added to the 
thorium/actinium solution (1:0.1:1:1 La:Ac:Th:POM), thorium is preferentially extracted (a1 
100 % and a2 88%.) over lanthanum (a1 0 % and a2 0%). and actinium (a1 5.6 % and a2 
4.9%).  
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Table 2.6. Single and mixed metal extractions with 225Ac using a1-WD and a2-WD 
Single metal Ac a1-WD a2-WD 
Actinium 73±6.1 83±3.6 
Mixed Metal Th/La/Ac a1-WD a2-WD 
Thorium 100±0.24 88±0.08 
Lanthanum 0±1.7 0±1.2 
Actinium  5.6±4.7 4.9±1.35 
Mixed Metal Th/Ac a1-WD a2-WD 
Thorium 100±0.08 89±0.5 
Actinium  3.01±1.4 11.3±5.0 
 
2.3.7 Kinetic Study 
To confirm that the extractions are not a matter of a formation of a kinetic product, a 
study was completed to confirm that the amount of time shaking the solutions does not affect the 
extractions. Here the extraction of single metals (thorium or lanthanum), at a 1:1 metal to POM 
ratio remains constant and the samples are shaken for 5 mins, 30 minutes, 1 hour, 2 hours or 24 
hours (see table 2.7). For each time point, the thorium extraction remained at 99% and the 
lanthanum extraction remained at 37%. This study demonstrates that the extraction is complete 
upon contact of the POM and the metal ions.  
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Table 2.7. Kinetic study of thorium and lanthanum extractions: For each metal ion, Th or La, five experiments at five 
time points were measured 
Time Thorium Lanthanum 
5 mins 98±0 38±0 
30 mins  99±0.0 38±0 
1 hour 99±0 40±0 
2 hours 99±0 36±0.0 
24 hours 99±0 37±0 
2.3.8 Order of Addition Study 
This study was done to examine the effect of the order in which the metals are added to 
the aqueous solution on the extraction. In this experiment, we varied the order of addition of the 
metals Th and La and the a2 POM. The order of addition was varied in three experiments as 
follows: POM: La:Th, POM, Th, La and Th, La POM. The results shown in table 2.8 show that 
extraction is identical for Th, La, and W(POM) for any ordering of addition. This experiment 
demonstrates that the extraction is consistent despite the order that the metals are added. It is 
important to note that the extraction of thorium is much lower than what has previously been 
observed (66% rather than 98%). We believe the low extraction is the result of the formation of 
oxides. This solution was not fresh and over time thorium can form oxides in aqueous solutions. 
Thorium oxide is a very stable complex and if thorium is bound to an oxide, it will not bind to the 
POM and therefore will not extract into the organic layer.   
Table 2.8. Order of addition study for thorium and lanthanum extraction 
 POM,Th,La POM, La,Th Th,La,POM 
Thorium 66±0.8 66.4±1.3 65.5±0.4 
Lanthanum 5±3.0 3.0±4.4 4.4± 
POM 99±0.1 99.3±0.1 99.2±0.0 
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2.3.9 Plenary and Lacunary Wells Dawson Study 
In order to better understand the mechanism of extraction, to determine whether the metal 
is extracted through the defect of the a2-WD and a1-WD POM and around to the surface of the 
POM, the intact plenary POM (Figure 2.1) with no defect was used in an extraction of thorium. 
Table 2.9 shows that there is no extraction at the 1:1 ratio of metal:POM (0%). Even at very high 
concentrations of POM (10 molar equivalents) there is only 23% extraction of thorium. This 
implies that the thorium sits inside the vacancy of the modified POM instead of being extracted 
through an electrostatic mechanism.   
Table 2.9. Thorium extraction with the plenary POM 
Metal to POM  Extraction  
Th : POM 1:1 2±0 
Th : POM 1:3 29±11 
Th : POM 1:5 22±7 
Th : POM 1:7 14±4 
Th : POM 1:10 23±16 
 
 
2.4 Discussion 
2.4.1 Mechanism of Extraction 
From our studies of the POM extraction, we can conclude that the extraction goes as 
follows, thorium coordinates to the POM in the a2-WD and a1-WD vacancy and then the 
thorium POM complex is extracted into the organic solution. This makes sense because the Th is 
a hard +4 oxophilic ion and would bind into the negatively charged, basic a2-WD and a1-WD 
vacancy which is comprised of 4 hard oxygen donors. Such a Th a2-WD or a1-WD complex 
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would be negatively charged and very likely a 1:1 Th:POM complex bearing a -6 charge, vide 
infra, and would ion pair with the octylammonium cations that are formed in the acidic solution. 
The large octylammonium molecule is organic-soluble and would carry the entire POM 
octylammonium species into the organic phase. With the plenary POM, there is no vacancy and 
essentially all of the charge (-6) is contained within the neutral (WO3)18 cage and not on the 
surface of the POM. Thus, the Th4+ will not covalently bind to the surface of the plenary POM 
but it possibly would experience electrostatic interactions. This is shown in the study of the 
extraction of thorium using the plenary or intact POM. As described above, there is a very small 
uptake of thorium with the plenary POM that is likely the result of a weak electrostatic 
interaction between the cationic thorium and the anionic POM.   
2.4.2 Correlation to stability constants and crystal structures 
Stability constants of the lanthanide and actinide complexes of the a2-WD and a1-WD 
POMs correlate with the extraction profiles of thorium, lanthanum, and actinium found in these 
studies. Also, crystal structure data provide information about the coordination environments and 
speciation of thorium, lanthanum, and actinium in aqueous and in organic phases. In previous 
studies in the Francesconi lab, stepwise stability constants, K1 and K2, equations 1 and 2, for Ln 
complexes of a1-WD and a2-WD were determined. Where K1 is the stability constant of a 1:1 
ratio between the POM and the metal and K2 is the stability constant of a 2:1 POM to metal ratio.  
(1) Ln  +  (a1/a2-P2W17O61)10-    (H2O)4Ln (a1/a2-P2W17O61)7-   K1 
Equation 1. Stability Constant for 1:1 POM : metal 
(2) (H2O)4Ln (a1/a2-P2W17O61)7- + (a1/a2-P2W17O61)10- Ln (a1/a2-P2W17O61)217-  K2 
Equation 2. Stability Constant for 2:1 POM : metal 
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For lanthanide complexes of (a1-P2W17O61)10-, Log K1 and log K2 were determined by 
competition experiments monitoring 31P NMR resonances that are characteristic for the 1:1 and 
1:2 Ln: a1-WD - complexes in the presence of a competitive ligand, EDTA, which is a well-
known chelator for lanthanide ions. With appropriate standards, 31P NMR spectroscopy allows 
direct determination of concentrations and allows the exact speciation to be monitored, when 
appropriate standards are applied.  
Comparison of conditional stability constants across the lanthanide series reveal a 
dramatic increase of log K1 across the lanthanide series. The log K2 decreases slightly across the 
series and it is also countercation (Li+, Na+, K+, and Cs+) dependent. The data are shown in 
Table 2.10.2 These studies provide compelling information that the later lanthanides with smaller 
ionic radii and high charge/size ratio form complexes with higher log K1 in the a1-framework. 
The Ln a1-WD data (K1, K2, log K1/log K2) are consistent with the conditional stability constants 
reported by Contant for Ce (III) complexes of the a1-WD isomer (1 M Li+ solution, log K1: 6.6; 
log K2: 1.5; log K1/log K2= 4.4) using spectrophotometric and potentiometric techniques. The 
log K1/log K2 ratio is an indicator to forming stable 1:1 Ln: POM complexes.2 This feature, along 
with the observation that complete or almost complete extraction of Th4+ occurs with 1:1 Th: 
POM stoichiometry bodes well for the formation of 1:1 Th: (a1-P2W17O61)10- complexes in the 
extractions.  
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Table 2.10 Conditional Stability Constants for Lanthanide complexes of α1-WD across the lanthanide series  
 
Lanthanide   La         Nd        Eu       Dy          Er Yb        Lu 
Log K1a 8.00 + 
0.17 
8.63+ 0.22   10.35+ 
0.22 
11.08 + 
0.15 
 11.62+ 
0.09 
12.21+ 
0.12 
12.50+ 
0.09 Log K2 
(Li+)b 
2.190 
+0.017 
2.069± 
0.025 
2.177± 
0.003 
2.132± 
0.008 
2.233± 
0.006 
1.874± 
0.007 
1.874± 
0.007 LogK2 
(Na+)b 
2.257 + 0.03 2.559± 
0.009 
2.421± 
0.022 
2.493± 
0.009 
2.264± 
0.021 
2.042± 
0.033 
2.042± 
0.008 Log K2 
(K+)b 
2.609+ 
0.015 
2.788± 
0.005 
2.785± 
0.008 
2.677± 
0.018 
2.351± 
0.024 
2.313± 
0.054 
2.139± 
0.026 Log K2 
(Cs+)b 
3.139+ 
0.026 
3.321± 
0.023 
3.220± 
0.041 
3.099± 
0.014 
2.517± 
0.006 
2.521± 
0.003 
2.185± 
0.006 Log K1/K2  3.65 4.17 4.75 5.19 5.20 5.98 6.67 
 
Ion Coordination no. Crystal Radii (Å) Ionic Radii (Å) Charge/size 
La3+ 8 1.30 1.16 2.59 
6 1.172 1.032  
Eu3+ 8 1.206 1.066 2.81 
6 1.087 0.947  
Lu3+ 8 1.117 0.977 3.07 
6 1.001 0.861  
Th4+ 8 1.19 1.05 3.8 
6 1.08 0.94  
 
 
The orientation of the PO43- tetrahedron in the (a1-P2W17O61)10- POM positions a basic oxygen 
atom near the a1 vacancy. This a1 site requires high charge/size cations for stabilization.12 The 
stability constant data for (a1-P2W17O61)10- (Table 2.10) are consistent with the high basicity of 
Table 2.11. Crystal and Ionic Radii of Th4+ and selected Lanthanide 3+ ions (Å) 
Table 2.10. Shows  the conditional Stability Constants for Lanthanide complexes of α1-WD across the lanthanide 
series.  K1cond determined from competition experiments, monitored by 31P NMR, using EDTA as a competitive ligand. 
Conditions: pH 4.75; 0.5M LiNO3; 25 oC. b K2cond determined by 31P NMR experiments, Conditions: pH 4.75; 0.02 M 
acetate (M: Li, Na, K, Cs), 25oC This table is with permission from Zhang2, C.  Inorg. Chem., 2005, 44, 3569-3578 
Table 2.11 shows crystal and Ionic Radii of Th4+ and selected Lanthanide 3+ ions (Å) Data abstracted from "Revised 
Effective Ionic Radii and Systematic Studies of Interatomic Distances in Halides and Chalcogenides" By R. D. Shannon. 
Acta Crystallographica. (1976). A32, Pages 751-767 
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the site requiring high charge/size cations for stabilization.12 This is consistent with the Th4+ 
extractions: Th4+, is considered a “hard” acid, with a high charge/size ratio compared to the 
lanthanides (Table 2.11), which should exhibit strong binding to the α1 binding site.  
Thermodynamic stability constants were also measured for lanthanide complexes of the 
(a2-P2W17O61)10- POM by the Francesconi lab57 (Table 2.12) and others58-61 by a variety of 
techniques. All of the stability constants are in excellent agreement between the different studies 
and suggest that the K1 and K2 remain constant over the series. Generally, the thermodynamic 
Log K1 and Log K2 reported in the above references are on the order of 9.35 -12.7 and 6 – 8.1, 
respectively, according to Lu58, Van Pelt59, 61, and Bion.60 
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The only study that compares stability constants and thermodynamics of Th4+ POMs with 
lanthanide POMs was conducted by Donald Wall for his Ph.D. work53 with G. Choppin at 
Florida State University. The relevant work with a2-WD - complexes have either been published 
in a review article62 or are not yet been published. However, the stability constant and 
thermodynamic data for Th4+: a2-WD compared with 3+ ions are consistent with the favorability 
of high charge/size or hard metal ions for the a2-WD defect site.  
31P NMR Method using EDTA as a competitive Liganda 
Ln La Pr Nd Eu 
Log K1 11.33 + 0.27 11.24  +  0.40 11.66 ± 0.20 11.40 ± 0.30 
Log K2 5.79 ± 0.27 7.18  +  0.40 6.26 ± 0.20 7.11 ± 0.30 
Log K1/K2 1.15 1.57 1.38 1.69 
Log b2 17.12 18.42 17.92 18.51 
Luminescence Titration Methodb 
Log K1    11.34 + 0.17 
Log K2    6.54 + 0.19 
Log b2    17.88 
a 31P NMR competition method: K1 and K2 determined frm competition experiments, monitored by 
31P NMR, using EDTA as a competitive ligand, pH 4.7, 0.5M LiOAc, 25oC 
b  K1 and K2 determined from a luminescence titration method 
Table 2.12.Thermodynamic formation constants for Ln(III) 
Table 2.12  Shows thermodynamic formation Constants for Ln(III): (α2-P2W17O61)10- 1:1 and 1:2 
complexes obtained from ligand-ligand competition studies and Luminescence Titration Method (for Eu 
(III)). Table was extracted with permission from Zhang2, C. Inorg. Chem., 2005, 44, 3569-3578 
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In the Wall research, calorimetric titration indicates formation of 1:1 and 1:2 Th: a2-WD 
complexes. The thermodynamic constants for Th4+ a2-WD complexes are log K1: 18.3 + 0.3 and 
log K2: 15.7 + 1.1 leading to a log β2 of 34.53 These constants are orders of magnitude above the 
thermodynamic formation constants for Ln (III): a1-WD complexes that we (Table 2.10) and 
others have determined, vide infra. The high stability constants for Th4+ compared to Ln3+ track 
well with strong binding of Th into the defect of the a2-WD POM compared to lanthanide +3 
ions, specifically La3+. These also track well with the ionic radii (Table 2.11) and are consistent 
with high charge/size ions showing favorable interaction with the a2-WD. 
Th4+ complexes of the plenary (a P2W18O62)6- Wells-Dawson POM were also examined 
in this thesis.  The plenary (a P2W18O62)6- Wells Dawson ion can be considered as two (PO4)3- 
moieties surrounded by a neutral (WO3)18 cage with the charge density on inside of the 
polyanion and very little surface charge. This notion has been born out experimentally and 
theoretically.63-70 As such, there should be little binding of cations to the Wells-Dawson ion. 
Unusually high stability constant data have been reported for Th : (a P2W18O62)6- complex (K1: 
11.3) very likely due to decomposition of the POM under the experimental conditions.53 
Decomposition of the plenary POM would produce the a2-WD with its vacancy. While this is 
orders of magnitude lower than for K1 of Th: a2-WD, the stability constant data for (a 
P2W18O62)6- should be revisited. Overall, these data track well with the extraction data, vide 
supra, that show little Th4+ extraction into the organic phase with the plenary (a-P2W18O62)6-. 
Crystal structure data of lanthanides (3+) and actinides (Ce4+, U4+, Th4+) of a1-WD and 
a2-WD POMs are similar and, along with extraction data, may reveal the speciation of thorium 
POMs, actinium POMs and lanthanum POMs that form in the extractions. There are two basic 
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types of structures formed: the 1:1 M: POM or the 1:2 M: POM (M= lanthanide +3 or actinide 
+4 ion). Considering the stoichiometry of extraction of 1:1 results in almost quantitative 
extraction of Th4+, La3+ and Ac3+ into the organic phase, it is very likely that the 1:1 M: POM 
complexes form for these metals and for both a1-WD and a2-WD. POMs. Moreover, the 
stability constant data (shown above) reveal higher K1 values than K2 stepwise stability constants 
which suggest the 1:1 complexes form.  
For the a2-WD POMs, two types of 1:1 complexes have been isolated and crystallized 
(Figure 2.2). The early lanthanides, La (III), Ce(III), and Pr (III), show “cap to cap” dimers.71 In 
the cap-to-cap structures, the lanthanide ion exhibits square antiprismatic coordination geometry 
and the lanthanide possesses 9-coordination. The lanthanide ion forms a “2:2” dimer where the 
Ln is bound to four oxygen atoms of the polyoxometalate, four water molecules and also to a 
terminal W-O bond in the “cap” region of an adjacent a2-WD unit, thus forming the 2:2 dimer.  
In the mid-late lanthanide complexes, the 1:1 Ln: a2-WD complexes display a different 
connectivity. Here, the lanthanide ion is 8-coordinate, and is also a 2:2 dimer. The Ln ion is 
bound to four oxygen atoms of the a2-WD, three water molecules and to a terminal W-O of the 
“belt” region of an adjacent a2-WD As expected, for both structural types, the bond lengths 
decrease across the lanthanide series. Given that the 1:1 Th4+: a2-WD extracts at close to 100% 
into the organic phase, we would expect that a 1:1 Th4+: a2-WD complex would form. Given that 
the ionic radius of Th4+ that is in the range of Eu3+ (see table 2.11) it may be expected that the 
cap to belt configuration would form.  
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Considering the a1-WD derivatives, the Francesconi lab found that the La, Eu, and Nd ions 
formed a 1:2 Ln: a1-WD complex while Yb and Lu formed only the 1:1 complex2, 72, tracking 
well with the conditional stability constants. Thus, given the high charge/size ratio of Th4+ 
(Table 2.11), we would expect that Th4+ would form the 1:1 species in accordance with the Lu3+ 
analog and with the fact that the (α1-P2W17O61) extracts Th4+ into the organic phase nearly 
quantitatively. 
 
 
Figure 2.2 Crystal structures of the solid-state structures of the 1:1 [Ln (a2-P2W17O61)2] 14-.  
 
Figure 2.3. Lu(H2O)4(α1-P2W17O61) 1:1 and 1:2 complexes.  
Left: Crystal structure of Lu(H2O)4(α1-P2W17O61)  Right: Crystal structures of  La, Eu, Nd: (α1-P2W17O61)  1:2 
complexes. Figure was abstracted with permission from Cheng, Z. et al j cluster science 2006 
Left, the “cap to cap” structure observed for the early lanthanides (La,Ce,Pr) that are 9-coordinate bound to 4 water 
molecules.  Right, the “cap to belt” structure observed for the mid-late lanthanides (Nd, Eu, Lu, and Y) Figure was 
abstracted with permission from Cheng, Z. et al j cluster science 2006 
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2.5 Conclusion 
In conclusion, thorium is preferentially extracted by the POM into the organic layer. This 
is due to the interaction between the relatively hard thorium cation and the hard oxygen atoms 
within POM. The other metals like lanthanum and cerium can also be extracted by the POM but 
only at high stochiometric ratios. This may be useful as cerium and lanthanum are also 
byproducts of the spallation process. POMs have previously been shown to coordinate to 
lanthanides, so there is a potential to use POMs in higher concentration for the extraction of the 
radiolathanide byproducts of spallation. In order for the thorium to extract, there must be a 
vacancy with in the POM. In equimolar mixed metal solutions, more than 90% of thorium is 
extracted into the organic solution while more than 90% of actinium remains in the aqueous 
layer. This shows that POM can absolutely be used as in extractant for thorium and actinium 
separation.  
2.6 Future work 
2.6.1 Investigation of the composition of the organic phase  
In order to gain a better understanding of the mechanism of extraction, the composition 
of the organic layer must be examined. It is believed that the Th-POM-octylamine extraction 
forms cluster involving thorium atoms, POMs and cations (octylammonium+, K+). This would 
explain the efficiency of extraction when the ratio of POM to thorium in less than 1:1. To 
determine if there is a cluster and its relative size, diffusion NMR (DOSY) can be employed. 
From the diffusion, the hydrodynamic radius of a molecule can be determined. The POMs 
contain at least 1 phosphorus atom; naturally abundant 31P is NMR active and can be measured 
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using diffusion NMR. X ray techniques using synchrotron radiation can be used as well to 
characterize the clusters formed in the organic phase. 
2.6.2 Scale up solvent extraction to gram quantities  
The optimal production process would use thorium targets on the order of 100 grams. In 
the preliminary experiments, the thorium extraction experiments were carried out using 
millimolar quantities. On this scale, 1:1 stoichiometry was found to optimize the separation of 
232Th and 225Ac. In order to properly probe the feasibility of this extraction method, these 
experiments must be completed on a larger scale. Therefore, we need to scale up the mass of 
thorium in the process and optimize the process with scaled-up thorium. We will scale up to 
gram quantities first, followed by tens of gram quantities. Commercially obtainable Th(NO3)4 
can be used as the thorium source for scaling up the extraction. The target for 225Ac production is 
thorium metal; this is converted to a ThIV solution during processing. We should also if possible, 
investigate solvent extraction studies using actual dissolved thorium targets. The parameters to 
be optimized will be stoichiometry of the POM, thorium, the acid, and the added salts. The 
advantage of using the POMs are that they are 1) radiation resistant; 2) stable in a variety of pH; 
3) commercially available in bulk quantities; 4) and inexpensive.  
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2.6.3 Employ commercially available POMs  
We used the POMs shown in Figure 1 for preliminary experiments because these are 
simply synthesized. However, for deployment in separation processes on large scale, 
inexpensive, commercially available POMs will be used. The Keggin type POMs: Na3PW12O40 
and H3PW12O40 are commercially available from Sigma. These POMs will be treated with mild 
base to form the PW11O397- species (Figure 8), which possess the appropriate ligand coordination 
environment to bind tightly to Th+4 and form stable Th+4 complexes, similar to the a1-WD and 
a2-WD. These will require extraction studies to ascertain their performance.  
2.6.4 Investigate precipitation strategies using POMs as alternative to solvent extraction 
POMs and their complexes can be precipitated from aqueous solution by judicious choice of 
counterion. Also, POMs can be supported on resins or cation exchange resins to carry out the 
above studies instead of solvent extractions. This may reduce waste and may provide a suitable 
solid-state matrix to execute the separations and for scale up. 
 
Figure 2.4. PW11O39 7- possesses a “defect” similar to 
the a2-WD 
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3. Thorium-227 Purification and Radiolabeling: a 
potential isotope for Radioimmunotherapy	
3.1 Thorium-227 for Targeted alpha therapy 
Targeted alpha therapy is becoming important in pre-clinical and clinical studies. The 
utilization of radioisotopes for curative therapy is poised to constitute a large significant portion 
of nuclear medicine. Since the 1960s, the availability of therapeutic radionuclides that provide   
α, β, and Auger electron emission has increased and new radionuclides are coming on line each 
year.73 131I has been used extensively to treat thyroid cancer via its β-emission. Two β-particle 
emitters 90Y and 131I were conjugated to antibodies targeting CD20 for treatment of non-
Hodgkin’s lymphoma. These were 90Y-labeled ibritumomab tiuxeran (Zevalin) that was 
approved by the FDA in 2002 and the other is 131I-labeled tositumomab (Bexxar) that was 
approved by the FDA in 2003. Thus, the basic infrastructure for radioimmunotherapy (RIT) has 
been in place for at least a decade and a half, and acceptance of RIT is widespread now among 
oncologists.   
Studies of α-particle emitting radionuclides for targeted alpha therapy with small 
molecules, peptides and nanoparticles is a growing area of interest and investigations. Pre-
clinical studies with α-emitters have been carried out for decades. Clinical alpha therapy 
treatment was initiated in patients in 1995 and these data were published in the literature in 
1999.74 Pre-clinical and clinical investigations of α-particle emitters have been driven in part by 
emphasis on isotope production, understanding and development of safe handling protocols, and 
development over the years of libraries of bifunctional chelators for conjugation of the 
radionuclides to targeting vectors. 223Ra, an α-emitting nuclide exhibits intrinsic bone-seeking 
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properties, while most α-emitting radionuclides require conjugation to targeting vectors to 
deliver the payload to appropriate cells.  
The physical properties of α-particles (short pathlength and high Linear Energy Transfer 
(LET)) are complementary to the long pathlength (< 12mm) and low LET (~2 keV/µm) of β-
particles Figure 3.1. α-particles possess short range in tissue (50 – 100 µm) and high LET (80 
keV/µm) and these properties are suitable to target small neoplasms or micro-metastases. 
Selective accumulation in diseased tissues is preferred to deliver an appropriate radiation dose to 
the tumor while limiting dose to normal organs and healthy tissue. β-particle emitting 
radionuclides should be effective in large, heterogeneous tumors where the long β-range evenly 
distributes the radiation dose. However, the long range of β-particles can result in irradiation of 
healthy tissue surrounding the tumor site. A recent clinical study highlighted the efficacy of α-
radiotherapy (225Ac) compared to 177Lu β-particle therapy75  
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Figure 3.1. Average particle range in cells for alpha and beta particles 	
 
Thorium-227 is a potentially useful isotope for targeted alpha therapy studies. Th-227 has 
a half-life of 18.7 days and also has four alpha emitting nuclides in its decay chain. While there 
are more pre-clinical and clinical studies with other alpha-emitting radionuclides, e.g. 225Ac, 
227Th is gaining in interest due to its lower dose rate than most current alpha-emitting 
radionuclides. This may be useful for treating cancer cells at different development stages which 
is a more efficient way of killing tumors.5 
Much of the pre-clinical research on 227Th has been conducted by Algeta Inc. (Bayer) in 
Norway in collaboration with the University of Oslow, Blindern, Oslo, Norway. In early studies, 
227Th was originally conjugated to the antibodies, trastuzumab and rituximab, an anti-CD20 
Alpha- vs. Beta-Particle Decay in the Body
Source: https://www.ncbi.nlm.nih.gov/books/NBK11474/ © National academy of sciences 
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monoclonal antibody. This work by Dahle and co-workers used the bifunctional chelator, p-
SCN-Bn-DOTA to coordinate 227Th to the antibody.76 The thorium labeled antibodies 
demonstrated in vitro and in vivo stability.77 The overall radiolabeling yield was 17% and the 
immunoreactivity of the 227Th-DOTA-rituximab was 56-65%. 
A brief summary of pre-clinical investigations using 227Th follows.  227Th-DOTA-
rituximab (5.4-27 µCi/kg) was administered to mice bearing Raji lymphoma xenografts resulting 
in delayed tumor growth and prolonged mean survival when compared with a control group. The 
mice did not experience serious toxicity. A significant tumor growth delay was achieved with a 
dose of 27µCi /kg (40 days) compared to the dose of 5.4 µCi /kg (17 days). The 227Th low-dose 
strategy appeared to be achievable against macroscopic tumor and single tumor cells 78  
In a study comparing the relative biological effects of α-radiation from 227Th -rituximab 
with both Zevalin (90Y-antibody) and external beam radiation demonstrated that α-radiation 
treatment with 227Th was 2.5 to 7.2 times more effective in inhibiting tumor growth than external 
beam radiation. b-radiation treatment with 90Y Zevalin was 1 to 1.3 times more effective than 
external beam radiation.79  
Nasir and coworkers80 compared the therapeutic effects of 177Lu and 227Th on HER2 
expressing ovarian cancer tumors. 227Th demonstrated a significantly better antitumor effect than 
177Lu using the same dose of radiation. The tumor growth was delayed further with 227Th and the 
mean survival was greater of the mice was longer. 
Investigation of 227Th-rituximab for long-term radiotoxicity involved injection of the 
construct into tumor bearing animals at 1.4, 5.4, and 27 µCi /kg and observation for one year. 
120 Mice treated with 27 µCi/kg experienced weight loss and decrease in white blood cells and 
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platelet count. This study determined that the “no-observed-adverse-effect” level was 5.4 µCi/kg 
and the “maximum tolerated activity” was determined to be between 16– 27 µCi/kg.81 
227Th-DOTA-trastuzumab was evaluated in two HER-2 positive breast cancer cell lines 
(BT-474 and SKBR-3) and in the ovarian cell line SKOV-3. 227Th-DOTA-trastuzumab inhibited 
cell growth and induced apoptosis in all cell lines at doses that were clinically relevant.82 Doses 
as low as 1.4 µCi/kg of 227Th antibody resulted in complete inhibition of growth in mice bearing 
human renal cell carcinoma subcutaneous xenografts. 83 Myelosuppression was observed in days 
44-65.  However, the mice recovered by day 114 and the toxicity was considered transient 
Brechbiel et al5 examined the use of 227Th for targeted alpha therapy for treatment of 
disseminated intraperitoneal disease. He concluded that 227Th is not an ideal candidate for 
radioimmunotherapy because of its toxicity. In his experiment, there was a high mortality rate in 
the mice of the study. It was postulated that the toxicity is the result of the decay of 227Th to 
223Ra which mimics calcium and accumulates in the bone.  
DOTA is the ligand that is mostly use for binding to 227Th. DOTA–antibody labeling has 
also been reported for 227Th by a 2-step method76 and by a 1-step method wherein the labeling 
proceeded overnight to afford high yield of the 227Th-DOTA-antibody.84 Both of these methods 
are not optimal. The “2-step” method is such that an isothiocyanate C-functionalized derivative 
of the DOTA chelator is first radiolabeled with 227Th and then conjugated to the antibody at 
37˚C.85 In this two-step method, low radiochemical yields are observed due to the hydrolysis of 
the isothiocyanate moiety.  
This work seeks to find a better chelator to coordinate 227Th to eliminate the 2-step 
process of labeling to an antibody. The chemistry of thorium mimics the chemistry of zirconium 
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which has been used to image tumors when chelated to antibodies. Deri et al86-87 used 3,4,3 
LI(1,2 HOPO) with 89Zr for PET imaging where 3,4,3 LI(1,2 HOPO) formed more stable 
complexes in vivo than the clinically used ligand desferrioxamine (DFO). Based on the ability to 
radiolabel HOPO-trastuzumab with 89Zr4+ at room temperature within one hour88 and the 
superior stability of 3,4,3 LI(1,2 HOPO)  for +4 metal ions, we hypothesized that 3,4,3 LI(1,2 
HOPO) can be radiolabeled with 227Th at room temperature or low temperature in one hour.  
Two studies provide encouragement for our hypothesis that the 3,4,3-(LI-1,2-HOPO) 
ligand and its bifunctional analog, p-SCN-Bn-HOPO, will form stable 227Th complexes easily 
and at low temperature. First, Abergel et al have demonstrated that the 3,4,3-(LI-1,2-HOPO) 
ligand forms macroscopic thorium complexes of extremely high stability. The stability constant, 
log β110= 40.1±0.5,89 is the highest stability constant recorded thus far for thorium. In fact, the 
3,4,3-(LI-1,2-HOPO) ligand was previously used as a decorporation agent for the treatment of 
internal exposure to actinides.90  
  In addition, Ramdahl prepared a different HOPO ligand, Me-2,3-HOPO, with a quite 
different structure and donor atoms in the 2,3-position of the hydroxypyridinone ring,91 as well 
as a bifunctional version of Me-2,3-HOPO. The bifunctional Me-2,3-HOPO was conjugated to 
the CD33-targeting antibody lintuzumab and radiolabeled with 227Th. The 227Th construct 
induced in vitro cytotoxicity on CD33-positive cells, manifested by accumulated DNA double-
strand breaks after exposure to the 227Th-lintuzumab. In a subcutaneous xenograft mouse model 
using HL-60 cells, the 227Th conjugate demonstrated antitumor activity in a single dose injection. 
Dose-dependent survival was demonstrated in a mouse tumor model after single dose injection 
or after fractionated dose administration.92 
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With the high stability of the macroscopic thorium complex of 3,4,3 LI(1,2 HOPO) and 
the success of the Zr-89 3,4,3 LI(1,2 HOPO) as a PET imaging agent, it is important to 
investigate the potential of 227Th 3,4,3 LI(1,2 HOPO) for targeted alpha therapy. This chapter 
describes the initial research on radiolabeling 227Th with bare 3,4,3 LI(1,2 HOPO), heretofore 
called HOPO and comparison with 227Th labeling of DOTA. Once the studies of the “bare” 
ligands are compared, we plan to conjugate the bifunctional HOPO to antibodies for 
radiolabeling and biological testing with 227Th. 
 
Figure 3.2. Structures of DOTA (left) and HOPO (right) ligands for 227Th labeling 
 
3.2 Thorium-227 properties and decay  
Thorium-227 has half-life of 18.7 days and decays via alpha particle emission to radium-
223. Radium-223 itself has a half-life of 11.4 days and decays to radon-219, polonium 215, lead-
211, bismuth-211, thallium-207, and finally lead-207 (stable). The decay scheme is shown in 
Figure 3.3. Figure 3.4 shows the transient equilibrium of 227Th (left panel) and the secular 
equilibrium of Radium-223 (right panel). 227Th and 223Ra are in transient equilibrium which 
means the half-life of the daughter is shorter than the half-life of the parent but is not-negligible 
compared to the parent half-life. In this case, the 223Ra daughter will grow in to higher activity 
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than the parent, 227Th. On the left panel of Figure 3.4, the half-lives of 227Th and 223Ra are 
similar so that the activity of the daughter, 223Ra, becomes greater than the activity of the parent 
at around the half-life of the parent, 227Th (18 days) and then decays. The total activity of the 
sample (activity of 227Th and 223Ra) increases up to 18 days and then decreases. over time as both 
the 227Th and the 223Ra decay. The decay of 223Ra to its radioactive daughters is best described as 
a secular equilibrium because the daughters of radium-223 have much shorter half-lives 
compared to the parent. The daughters will grow in over time. The total activity (223Ra and 
daughters) steadily declines over time. These complex equilibria can prove problematic for 
radiolabeling with partially decayed thorium-227 because the increase of the daughters of 223Ra 
can decrease the labeling yield and increase the dose. One of the daughters, 211Pb, can compete 
with thorium for ligands. Both Pb and Th can exist as +4 metals and can be coordinated to the 
same ligand. One way to facilitate radiolabeling and analysis is to purify the 227Th prior to 
radiolabeling, eliminating the daughters so that can ensure that only thorium-227 is available for 
labeling. 	
 
Figure 3.3.Thorium-227 decay chain and the oxidation states of selected daughters. 
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Figure 3.4.The radioactive decay and growth pattern of 227Th and 223Ra.  
 
3.3 Purification (theory and practice)  
Labeling with partially decayed thorium reduces yields of the 227Th product, and more 
importantly, due to the unlabeled daughter isotopes the toxicity may increase in vivo. Thorium-
227 can be purified using an anion exchange column. Thorium forms an anionic complex, 
[Th(NO3)6]2-, at high concentrations of nitric acid (>7 M).25-26, 93-96 This complex binds strongly 
to anion exchange resins. The daughters of thorium (radium, radon, polonium, lead, bismuth, 
thallium), do not form anionic complexes at high concentrations of nitric acid, and thus will elute 
from the column in the loading fraction. Thorium can be eluted by lowering the concentration 
and thus decomposing the [Th(NO3)6]2 complex. The employment of an anion exchange resin to 
purify 227Th and separate pure thorium-227 from the daughters improves the radiolabeling 
process and allows for convenient analysis since the daughters are not present at the onset. The 
Left: the transient equilibrium of 227Th and 223Ra; Right: the secular equilibrium of 223Ra and its short-lived daughters 
Source: This image was reproduced with permission from Elsevier. Mitsugashira et. al. Nuclear Medicine and Biology 
7, 2004, 901-908 
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employment of an anion exchange resin to purify or separate thorium is a convenient and 
important approach to ensure purity. 
When it comes to radiolabeling, the purity of thorium-227 is important for two reasons: 
first, the purity of 227Th is essential to optimize the radiolabeling yield. Thorium is a +4 
oxophillic metal. The first decay daughter of thorium-227 is radium-223, which will not 
radiolabel with conventional ligands and constitutes a radioactive impurity metal that can 
contribute to toxicity. 223Ra will localize in the bone. The daughters of 223Ra may or may not 
compete with the thorium for the chelators of ligands during labeling. This is especially true for 
universally employed ligands such as DOTA. One daughter of 223Ra that can bind into DOTA is 
211Pb (t1/2:  36 minutes, β- 1.38 MeV). Lead can be in either the +2 or +4 oxidation state. The 
ligand DOTA binds very well to Pb+4 and this will reduce yields of the Th+4 DOTA product. 
However, if the Pb DOTA complex is stable in vivo, this may not contribute to the toxicity as the 
Pb will be bound tightly to the ligand. The other daughters of 223Ra will not bind DOTA 
efficiently and can contribute to toxicity in vivo. In particular, in Radioimmunotherapy (RIT), the 
daughter isotopes of Radium-223, that are not chelated, can contribute to in vivo toxicity. One 
way to circumvent the presence of the 223Ra daughters in RIT is to conduct experiments with 
thorium labeled antibodies using freshly purified thorium. 
3.4 Methods and Materials 
General considerations for handling alpha emitters 
227Th is an alpha emitter with alpha-emitting daughters All syntheses and handling of 
solutions were conducted in a laboratory approved for manipulation of alpha emitting 
radionuclides with certified HEPA filtered fume hoods and monitored with α, β, and γ detecting 
instruments. 
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3.4.1 Reagents  
227Th (99.99 % RCP) was obtained from Oak Ridge National Laboratory through the 
United States Department of Energy Office of Science Isotope Program in the Office of Nuclear 
Physics. 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) was obtained from 
Macrocyclics. Ammonium acetate was obtained from Sigma. Chelex (to remove free metal ions) 
and MP-1 M (anion exchange resin for the purification of 227Th) resins were obtained from BIO-
RAD. Deionized water (18 MΩ) was obtained from a 0.22 µm Millipore water system and 
passed through a Chelex column to remove any trace metals (Chelex Water). The ligand 3,4,3 
(LI-1,2 HOPO), HOPO from here on, was synthesized in house.97  
3.4.2 Analysis 
3.4.2.1 iTLC- Instant Thin Layer Chromatography 
iTLC is a commonly used method to determine the radiochemical yield of labeling 
reactions. The iTLC is comprised of a proportional gas counter whose signal is directly 
proportional to the energy of the particle emitted. As previously mentioned in chapter 1, alpha 
particles are not very penetrating and therefore do not travel very far once emitted. iTLC is not 
very efficient the detection of alpha emitters. Beta emitters however are very easily detected via 
iTLC. One daughter of 227Th is Pb-211. This nuclide emits a beta particle at 1.38 MeV. If the 
thorium has partially decayed, the iTLC readings will reflect the behavior of the 211Pb due to the 
high energy beta. Unless the thorium used has been purified very recently iTLC is not a very 
good method for determining the radiochemical purity of thorium labeled compounds. The 
gamma of 227Th can be detected using iTLC but the thorium should be purified prior to 
radiolabeling so that daughters will not be present. Even so, for stability studies over time (such 
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as weeks) where daughters will grow in due to the decay of 227Th, iTLC may not be the optimal 
technique for analysis.  
3.4.2.2 High Purity Germanium Detector (HPGe) 
Thorium-227 has a gamma emission at 236 keV. This gamma energy can easily be 
detected using high purity germanium (HPGe) gamma spectroscopy. The benefits to gamma 
spectroscopy is that each element within the solution can be identified using the proper library. 
HPGe possesses higher resolution than the thallium-doped sodium iodide NaI(Tl) detectors; thus 
we can quantitate the activity of 227Th and its daughters. Using gamma spectroscopy is 
advantageous for the accuracy of the measurements. However, with many samples it can be very 
time consuming as each sample is counted for roughly 10 minutes. 
3.4.2.3 Dose Calibrator to measure activities of 227Th 
In some of the experiments in this study, we generated many samples where we needed to 
measure the activity. Measuring activities using the High Purity Germanium (HPGe) detector is 
time consuming, taking at least 10 minutes per sample. Employing a dose calibrator to determine 
the activity of a sample is convenient and allows processing of samples in a reasonable amount 
of time.  We found that measuring the activity of a radioactive sample can be accomplished 
quickly using a dose calibrator that has been standardized against a HPGe detector. Since the 
dose calibrator cannot distinguish between isotopes, the dose calibrator was calibrated using the 
thorium stock used for the reactions. This is done to compensate for the increase of activity from 
the growth of the daughters. 
The dose calibrator is an instrument that allows activities of radioisotopes to be 
determined. This is heavily used in a hospital when the activities or doses are important for 
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administration of a radiopharmaceutical to a patient. In this project, we used the dose calibrator 
(Capintec CRC-55tPET) to quickly determine activities of 227Th.  
The dose calibrator is essentially an ionization chamber. Radiation ionizes the gas in the 
ionization chamber to ion pairs. Electrons move to the anode and that results in a current readout. 
The current is proportional to the number of ion pairs formed, which is related to the activity of 
the isotope. The instrument is calibrated so that it can be set to measure the radioactivity of a 
specific radionuclide. The instrument cannot discriminate between energies. Before each 
experiment, a thorium sample was measured on the high purity germanium detector focusing on 
the 236 keV gamma ray to obtain the exact activity, and this sample was used to standardize the 
dose calibrator to the appropriate activity in microcuries.    
3.4.2.4 Purification of Thorium-227  
3.4.2.4.1 Purification procedure  
As mentioned above, over time, thorium-227 decays to 223Ra in a transient equilibrium. 
Radium itself experiences a secular equilibrium wherein it decays to other daughters that can 
interfere with radiolabeling. The purification procedure we used to obtain pure 227Th is a 
modified method of what is done at Oak Ridge National Laboratory (ORNL).24 In our modified 
method, 200-400 mesh MP1 BioRad resin was presoaked in water. The resin was then added to a 
0.8 cm internal diameter plastic column to make a 200 µl bed volume (B.V.) column. Glass wool 
is then placed on top of the column to avoid disturbing the top layer of resin. The column is then 
treated with 3 B.V. of 8 M nitric acid. An aliquot of partially decayed solution of 227Th in 0.1 M 
HCl (50 µl) is dissolved in 8 M nitric acid to make a 200 µl solution. The solution is then loaded 
on the column and the column is then rinsed with 8 B.V. of 8 M nitric acid to remove the 
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daughters. The thorium is then eluted with 2 ml in 200 µl fractions of 0.1 M nitric acid and 
counted on the HPGe. 
Our method does not evaporate the sample to dryness as is done at ORNL. We do not 
evaporate the sample, in order to save time and to mitigate the risk of contamination from boiling 
samples containing alpha emitting radionuclides. In our modified method, the bed volume of the 
column was reduced to 200 µL and the elutions are fractionated in order to maximize the specific 
activity of the elutions for labeling. 
3.4.2.5 Radiolabeling with ligands DOTA and HOPO 
3.4.2.5.1 Synthesis of 227Th DOTA  
The following radiolabeling, or synthesis procedures use different sources of thorium-227 
and the source may impact the yields due to daughters. We are designating the syntheses as F, D. 
P, and pH for Fresh, Decayed, Purified, and pH adjusted sources of thorium-227, respectively.  
3.4.2.5.2.1 Synthesis using fresh thorium stock solution to prepare Th-DOTA (Th-
DOTA(F))  
The fresh 227Th stock solution was obtained from ORNL and used immediately (purity 
verified with HPGe <1% 223Ra and 0% 211Pb). For radiolabeling, a 10-30 µCi aliquot was added 
to a solution of DOTA (60 µg, 0.148 nmol) in a 0.1 M NH4OAc at pH 5 to make a total reaction 
volume of 200 µl. The solution was allowed to react for 1 hour in a thermomixer (Eppendorf 
ThermoMixer F1.5) at 50˚C. The complex was purified on a 300 µl Chelex column which was 
pretreated with the 0.1 M NH4OAc, pH 5 buffer solution. The Chelex column complexes free 
metal ions (e.g 223Ra and its daughters) and thus allows only the 227Th DOTA neutral complex to 
elute from the column. The compound was loaded on to the column and eluted with 2 ml 0.1 M 
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NH4OAc at pH 5 in two 1-ml fractions. The reaction was quantified using the dose calibrator; the 
reaction vial, purification column, and the fractions from the purification column were all 
counted, and the yield was determined. Reaction vial: 2.8±1.7% activity Column: 23.4±0.6% 
activity, Load: 0.16±0.11% activity, Fraction 1: 62.3±4.1% activity, Fraction 2: 12.9±3.4% 
activity. The total yield of the reaction (Fraction 1 + Fraction 2) was found to be 75.9±1.3%  
3.4.2.5.2.2 Synthesis using decayed thorium stock solution to prepare Th-DOTA (Th-
DOTA(D))  
A 10-30 µCi aliquot from a 227Th stock solution, (purity verified with HPGe 48% 223Ra 
61.3% 211Pb) was added to a solution of DOTA (60 ug, 0.148 nmol) in a 0.1 M NH4OAc at pH 5 
to make a total reaction volume of 200 µl. The solution was reacted for 1 hour in a thermomixer 
(Eppendorf ThermoMixer F1.5) at 50˚C. The complex was purified on a 300 µl Chelex column 
which was pretreated with the 0.1 M NH4OAc, pH 5 buffer solution. The Chelex column 
complexes free metal ions including complexes 223Ra and its daughters, and thus allows only the 
227Th DOTA neutral complex to elute from the column. The compound was loaded on to the 
column and eluted with 2 ml 0.1 M NH4OAc at pH 5 in two 1-ml fractions. The reaction was 
quantified using the dose calibrator, the reaction vial, purification column, and the fractions from 
the purification column were all counted, and the yield was determined. Reaction vial: 
0.05±0.9% Column: 23.4±0.6% activity, Load: 0.023±0.020% activity, Fraction 1: 35.8±4.6% 
activity, Fraction 2: 13.9±1.0% activity. The total yield of the reaction (Fraction 1 + Fraction 2) 
was found to be 48.3±1.9%  
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3.4.2.5.2.3 Synthesis using purified thorium stock solution to prepare Th-DOTA(Th-
DOTA(P)) 
A 10-30 µCi aliquot from the purified 227Th solution, (see section 2.3.1) (purity verified 
with HPGe <0% 223Ra and 1.03% 211Pb) was added to a solution of DOTA (60 ug, 0.148 nmol) 
in a 0.1 NH4OAc at pH 5 buffer to make a total reaction volume of 200 µl. The solution was 
reacted for 1 hour in a thermomixer (Eppendorf ThermoMixer F1.5) at 50˚C. The complex was 
purified on a 300 µl Chelex column which was pretreated with the buffer solution. The Chelex 
column complexes free metal ions including complexes 223Ra and its daughters, and thus allows 
only the 227Th DOTA neutral complex to elute from the column. The compound was loaded on 
to the column and eluted with 2 mL 0.1 M NH4OAc at pH 5 in two 1-ml fractions. The reaction 
was quantified using the dose calibrator; the reaction vial, purification column, and the fractions 
from the purification column were all counted, and the yield was determined. Reaction vial: 0% 
Column: 23.4±0.6% activity, Load: 0.04±0.06% activity, Fraction 1: 6.0±2.6% activity, Fraction 
2: 1.4±0.6% activity. The total yield of the reaction (Fraction 1 + Fraction 2) was found to be 
8.1±3.6%  
3.4.2.5.2.4 Synthesis using purified, pH adjusted thorium stock solution to prepare Th 
DOTA (Th-DOTA(pH))  
A 10-30 µCi aliquot of the purified (see section 2.3.1) (acidic) 227Th (purity verified with 
HPGe <0% 223Ra and 0.63% 211Pb) was added to a solution of DOTA (60 µg 0.148 nmol) in 0.1 
M NH4OAc at pH 5. 100 µl of 3 M NH4OAc was added to the reaction mixture to adjust the pH 
to 5 resulting in a total solution volume of 300 µl. The solution was reacted for 1 hour in a 
thermomixer (Eppendorf ThermoMixer F1.5) at 50˚C. The complex was purified on a 300 µL 
Chelex column which was pretreated with the buffer solution. The Th-DOTA complex was 
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eluted with 2 ml 0.1 M NH4OAc at pH 5 in two 1-ml fractions. The reaction was quantified using 
the dose calibrator, the reaction vial, purification column, and the fractions from the purification 
column were all counted, and the yield was determined. Reaction vial: 0.8 ±3.1% Column: 
23.4±0.6% activity, Load: 0.049±0.85% activity, Fraction 1: 48.6±1.3% activity, Fraction 2: 
10.4±1.1% activity. The total yield of the reaction (Fraction 1 + Fraction 2) was found to be 
58.0±.2.1%  
3.4.2.5.3 Synthesis of 227Th -HOPO 
The following radiolabeling or synthesis procedures use different sources of thorium-227 
and the source may impact the yields due to daughters. As before we are designating the 
syntheses as F, D. P, pH for Fresh, Decayed, Purified, and pH adjusted sources of thorium-227, 
respectively.  
3.4.2.5.3.1 Synthesis using fresh thorium stock solution to prepare Th HOPO (Th-
HOPO(F))  
A 10-30 µCi aliquot from a fresh 227Th stock solution, (purity verified with HPGe <1% 
223Ra and 0% 211Pb) was added to a solution of HOPO (60 µg, 0.079 nmol) in a 0.1 M NH4OAc 
at pH 5 buffer to make a total reaction volume of 200 µl. The solution was reacted for 1 hour in a 
thermomixer (Eppendorf ThermoMixer F1.5) at 50˚C. The complex was purified on a 300 µl 
Chelex column which was pretreated with the buffer solution. The compound was loaded on to 
the column and eluted with 2 ml 0.1 M NH4OAc at pH 5 in two 1-ml fractions. The reaction was 
quantified using the dose calibrator; the reaction vial, purification column, and the fractions from 
the purification column were all counted, and the yield was determined. Reaction vial: 
18.1±4.4% Column: 23.4±0.6% activity, Load: 0.20±0.071% activity, Fraction 1: 60.7±2.3% 
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activity, Fraction 2: 9.8±0.5% activity. The total yield of the reaction (Fraction 1 + Fraction 2) 
was found to be 69.9±3%  
3.4.2.5.3.2 Synthesis using purified thorium stock solution to prepare Th HOPO (Th-
HOPO(P))  
A 10-30 µCi aliquot from a purified (acidic) thorium solution, (purity verified with HPGe 
<0% 223Ra and 1.03% 211Pb) was added to a solution of HOPO (60 µg, 0.079nmol) in NH4OAc 
at pH 5 to make a total reaction volume of 200 µl. The solution was reacted for 1 hour in a 
thermomixer (Eppendorf ThermoMixer F1.5) at 50oC. The complex was purified on a 300 µl 
Chelex column which was pretreated with the buffer solution. The compound was loaded on to 
the column and eluted with 2 ml 0.1 M NH4OAc at pH 5 in two 1- ml fractions. The reaction was 
quantified using the dose calibrator; the reaction vial, purification column, and the fractions from 
the purification column were all counted, and the yield was determined. Reaction vial: 
14.0±4.0% Column: 23.4±0.6% activity, Load: 0% activity, Fraction 1: 63±12% activity, 
Fraction 2: 13.5±5.4% activity. The total yield of the reaction (Fraction 1 + Fraction 2) was 
found to be 77.5±7.1%  
3.4.2.5.3.2 Synthesis using purified thorium stock solution to prepare Th HOPO (Th-
HOPO(pH))  
A 10-30 µCi aliquot from a purified (acidic) thorium solution, (purity verified with HPGe 
<0% 223Ra and 0.63% 211Pb) was added to a solution of HOPO (60 µg, 0.079 nmol in 0.1 M 
NH4OAc at pH 5. 100 µl of 3M NH4OAc was added to the reaction mixture to adjust the pH to 5 
resulting in a total solution volume of 300 µl. The solution was reacted for 1 hour in a 
thermomixer (Eppendorf ThermoMixer F1.5) at 50˚C. The complex was purified on a 300 µl 
Chelex column which was pretreated with the buffer solution. The compound was loaded on to 
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the column and eluted with 2 ml 0.1 M NH4OAc at pH 5 in two 1-ml) fractions. The reaction 
was quantified using the dose calibrator. The reaction vial, purification column, and the column 
fractions were all counted, and the yield was determined. Reaction vial: 14.2±2.1% Column: 
18.6±2.3% activity, Load: 0% activity, Fraction 1: 67±10% activity, Fraction 2: 13.7±4.5% 
activity. The total yield of the reaction (Fraction 1 + Fraction 2) was found to be 79.7±5.6%  
3.4.2.5.4 Stability studies  
3.4.2.5.4.1 Th-DOTA and Th-HOPO  
The stability studies were performed in triplicate. Three 100 µl aliquots of Th-DOTA 
(pH) were taken out for each time point and dissolved in 1150 µl of phosphate buffered saline 
(PBS). Th-HOPO(pH) were dissolved in 450 ml of PBS. The samples were then incubated at 37 
oC. At the prescribed time points (1 hour, 4 hours, 1 day, 4 days, 7 days and 14 days) The 
aliquots were loaded onto a Chelex column with a bed volume of 1 ml, and the activity was 
eluted with 0.1 M NH4OAc at pH 5 in 2 (1ml) fractions. The activity was determined by the dose 
calibrator that was standardized with a sample of 227Th before use. 
3.5 Results and Discussion 
3.5.1 Column purification 
We successfully purified the thorium-227 using the modified ORNL method. The yields 
were determined using HPGe, Figure 3.5. Fraction L0 is the load fraction, meaning the this is 
the fraction where thorium was added to the column, displacing the bed volume of the column. 
Fractions L1-L4 are the wash fractions where the daughters of thorium are eluted from the 
column using 8 M nitric acid. In fractions L1-L4, 211Pb (79% activity), 211Bi (86% activity) and 
223Ra (86% activity) are all observed and 227Th (0% activity) is not observed. This shows that 
thorium was completely bound to the column while the daughters were not bound and thus 
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washed out. Fractions E1-E10 show the elution of thorium from the column using 0.1 M nitric 
acid. Fractions E1 and E2 show no activity. Fraction E3 shows a small amount of 227Th (3.2% 
activity). Fraction 4 contains the majority of the activity (77%); 227Th as well as a small amount 
of the daughters (5 % activity) are present in the sample. Fractions 5 and 6 contain activity (17 % 
and 5% respectively) but in small amounts that may be too dilute for radiolabeling. Fractions E7-
E10 contain negligible amounts of 227Th (3% activity). The column was quite successful as the 
227Th was >95% pure and the majority (~77%) of the activity coming off the column is in 
fraction 4 (E4). This is very promising for streamlining the purification and labeling process.  
 
Figure 3.5. Elution Profile of 227Th purification column 
3.5.2 DOTA Labeling 
In this work, the yield of the Th-DOTA reactions as a function of purity was examined. 
3.5.2.1 Fresh Thorium vs Decayed Thorium 
Table 3.1 shows the labeling reactions of Th-DOTA, either using “fresh” thorium directly 
obtained from ORNL and used immediately (yield 75.95%), or in the case where the thorium-
227 had partially decayed to daughters (yield 48.27%). As expected, the labeling yield is 
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significantly reduced in the sample containing daughters. The unpurified 227Th contained 
significant amounts of 211Pb, comprising 61.3% of the total activity. Pb can exist in the +2 or +4 
oxidation states and the +4-oxidation state will likely compete with Th4+ for the DOTA ligand, 
thus, lowering the labeling yield for Th-DOTA.  
Table 3.1 Percent labeled Th-DOTA with fresh thorium-227 vs partially decayed thorium 
 
Reaction  % Yield 
Th-DOTA(F) 75.9±1.3% 
Th-DOTA(D) 48.27±1.9% 
 
3.5.2.2 Purified Th with DOTA  
The labeling with the freshly purified 227Th was very low yield (8%), considerably lower 
than the yield for partially decayed 227Th (48%). While the purification column (see section 
2.3.1) removes the daughters, it also is highly acidic, and the acid negatively impacts the 
radiolabeling conditions. As previously mentioned, the purification column uses 0.1 M HNO3 to 
elute thorium from the column. Since thorium is loaded onto the column that is stored in 8 M 
nitric acid, upon elution, the concentration of the acid is actually higher than 0.1 M. The high 
concentration of nitric acid (low pH) greatly reduces the yield of the reaction. This is due to the 
DOTA ligand itself, at low pH, the ligand remains protonated. In order for DOTA to coordinate 
metals, the protons from the carboxylic acid groups must be stripped. To rectify this, the pH of 
the labeling solution was adjusted to 5 using 3M NH4OAc and the increase in pH did result in an 
increase in the yield. Table 3.2 compares the Th DOTA reactions. In these experiments, the 
yield with the pH-adjusted purified thorium (58%) approaches but did not surpass the yield of 
the fresh thorium (76%). 
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Table 3.2 Labeling results of Th-DOTA reactions from different stocks of 227Th (fresh, partially decayed, pH adjusted, 
and purified with no pH adjustment) 
Reaction  % Yield 
Th-DOTA(F) 75.9±1.3% 
Th-DOTA(D) 48.27±1.9% 
Th-DOTA(pH)) 58.0±.2.13% 
Th-DOTA(P) 8.08±3.6% 
 
	
3.5.3 Th-HOPO Labeling   
The yield of the Th-HOPO reactions with purified 227Th, fresh 227Th, and pH adjusted 227Th 
were examined. The yields are shown in table 3.3. The data in the table represents the labeling 
reactions of Th-HOPO using “fresh” thorium (yield 70%), purified HOPO (yield 77.5%), and 
pH-adjusted thorium (yield 80%). Unlike DOTA, the HOPO ligand is not affected by the pH of 
the solution. The insensitivity to pH of HOPO is likely due to two factors. First, the very high 
stability constant of Th4+ HOPO 98 means that Th +4 very effectively competes with protons for 
binding to the HOPO. Th stability constants for DOTA have not been measured but likely are not 
as high. A second factor contributing to the invariance of pH for complexation of 227Th is likely 
due to the pKa of the ligands. Both the 1,2-HOPO and the carboxylate of DOTA are effective at 
binding Th+4; DOTA appears to be more basic and therefore, harder to deprotonate at low pH. 
The overall basicity of the ligand can be quantified by the sum of the log Ka values associated 
with the four deprotonation steps of the ligand. For HOPO: Slog Ka = 21.3. For DOTA, the sum 
of the log Ka values99,100 is 29.63. The higher acidity of HOPO facilitates its binding at lower pH 
compared to DOTA.  
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Table 3.3 Labeling of HOPO with purified but not pH adjusted, fresh thorium and pH adjusted thorium 
Reaction  % Yield 
Th-HOPO(F) 69.9±3.08% 
Th-HOPO(pH)) 77.5±7.12% 
Th-HOPO (P) 79.69±5.6% 
	
3.5.4 Comparison of Radiolabeling of HOPO (pH) vs DOTA (pH) with purified 227Th 
In this experiment, a comparison of the labeling of DOTA and HOPO ligands with 
purified, pH corrected thorium was conducted. The yield of the DOTA reaction is 
58.0±.2.13%while the yield of the HOPO reaction is 77.5±7.12% (table 3.4). This may be due 
to different ligand donation from the DOTA and the HOPO. Both ligands are octadentate 
ligands, meaning that they donate eight groups to the metal. DOTA donates 4 nitrogen and 4 
oxygen atoms and HOPO donates 8 oxygen atoms. Being that thorium is an oxyphilic metal it 
should preferentially coordinate to ligands with more oxygen donors.  
 
Table 3.4 Th-DOTA vs HOPO yield comparison 
Reaction  % Yield 
Th-DOTA (pH) 58.0±.2.13% 
Th-HOPO (pH) 77.5±7.12% 
 	
 75 
3.5.5 Stability studies of Th DOTA and Th HOPO 
The stability of the compound was studied in phosphate buffered saline, which is the 
common solvent for in vivo studies. This is the first of many studies to determine the in vivo 
stability of the thorium complexes. After 1 hour, nearly 80% of the Th-DOTA complex 
decomposed. The remaining 20% remained stable for 4 days. After 7 days, 12% of the 
compound remained intact. After 14 days only 1% of the compound remained. Th-HOPO is a far 
more stable compound, after 1 hour about 45% of the compound decomposed. After 7 days 50% 
of the compound remained intact. The increase in activity may be due to instrumental errors. As 
the daughters of thorium grow the errors for quantifying small quantities of thorium with dose 
calibration increase. There was only a 5% loss of total activity over the course of 7 days and after 
14 days, 20% of the Th-HOPO complex remained. The time course stability experiments 
comparing DOTA and HOPO are shown in Figure 3.6.   
This set of experiments is the first of many that will be conducted to compare the 
radiolabeling and stability of 227Th with HOPO and DOTA.  Based on the demonstrated 
chemistry of M+4 metal ions with HOPO, we postulate that HOPO will be an ideal ligand for the 
coordination of thorium. We produced the bifunctional version of HOPO86-87, which may 
facilitate the use of 227Th for targeted alpha therapy. 227Th possesses a half-life that is consistent 
with the biological residence time of monoclonal antibodies, mAbs, which is on the order of 
days. Therefore 227Th is an excellent radionuclide for radioimmunotherapy (RIT).  
Deblonde and Abergel determined the Th+4 HOPO stability constant to be log β110 38.5.  
This is the highest stability constant for Th4+ recorded.98 The stability constant for Th DOTA has 
not been measured but the stability constant for a similar compound, Th DTPA (log β110) is 28.7. 
While DOTA is universally used as a chelating agent, in part due to its availability, this ligand 
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generally lacks fast kinetics of complexation.101 One reason DOTA is slow to complex 
lanthanides and actinides is the formation of an initial species where the metal is complexed only 
to the oxygen atoms, followed by a deprotonation of the amine nitrogen atoms and movement of 
the metal ion into the cavity to form the square antiprismatic coordination complex of DOTA.102 
Generally, DOTA requires heating for complexation of metal ions such as Th+4 or 
lanthanide(III). Antibodies are sensitive and cannot be heated to temperatures required for 
labeling DOTA. Therefore, the need for heating to achieve for complexation often translates into 
a two-step labeling approach wherein the bifunctional DOTA, e.g. p-SCN-Bn-DOTA, is labeled 
first with Th+4 followed by conjugation of the Th+4 DOTA construct to an antibody. This 
approach suffers from loss of the DOTA ligand due to hydrolysis of the p-SCN group. 
HOPO, alternatively, displays rapid metal complexation kinetics.89 The rapid 
complexation kinetics along with the insertion of a conjugating linker through one of the amide 
groups on the spermine backbone88, as well as its preclinical characterization as a decorporating 
agent103-104 renders HOPO to be a promising ligand for the development of future 227Th targeted 
alpha therapy agents.  
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Figure 3.6. Stability Study of Th-HOPO vs Th-DOTA 
	
3.6 Conclusions  
We have successfully streamlined the process of purification of 227Th on using a modified 
version of the ORNL method. This modified method takes into account smaller amounts of 
radioactivity, time constraints and the need to mitigate alpha contamination. Using our method, a 
researcher can purify 227Th and label within hours if necessary. This is very advantageous for any 
studies that are time and purity dependent. We have also developed procedures for radiolabeling 
227Th with ligands, specifically HOPO and DOTA. We found that the HOPO ligand appears to 
be superior for coordination of 227Th and stability of the 227Th complex in comparison to DOTA. 
This is the result of the functional groups on the ligand that chelate to the metal. DOTA donates 
4 oxygen atoms and 4 nitrogen atoms while HOPO donates 8 oxygen atoms. The evidence of 
HOPO’s superiority lies in the labeling yields and the stability of the complexes over time. 
Future work will examine of the stability of the compounds using fresh 227Th to see if the 
stability is affected by the acid from the elution process.  
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4. Technetium Speciation in Ionic Liquids 
4.1 Introduction 
The use of ionic liquids (ILs) in the nuclear fuel cycle has been probed for the past few 
years, the most common application being extraction of radionuclides in potential reprocessing 
strategies. ILs have been shown to extract fission products from aqueous solutions, and Hussey 
and coworkers105 successfully extracted and deposited strontium using ILs. It is of great interest 
to examine the possibility of applying ILs to the separation and extraction of another fission 
product, technetium-99.  
Ionic liquids (IL) are salts that are liquid at or below 100°C. They are comprised of bulky 
ions with low molecular symmetry; the lack of symmetry frustrates packing and prevents the 
ions from organizing enough to form a high melting crystalline solid. The cations and anions of 
ILs can be mixed and matched to have customizable properties. For this reason, ILs are often 
referred to as designer solvents. The properties that can be varied include but are not limited to, 
volatility, solubility, and viscosity.  
The fact that ILs are customizable means that they can be used in a wide range of 
applications, such as lignocellulose processing, solar energy conversion, and nuclear fuel and 
separations.106 The application most relevant for this work is nuclear fuel waste processing. 
Given their recyclability, if ILs can be used in nuclear fuel separations, it would be advantageous 
as it would reduce the amount of waste generated during nuclear waste processing.  
With all the different cation and anion combinations, there are an infinite number of 
possible ionic liquids with various anions and properties. This study will focus solely on 
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trimethylbutylammonium bis(trifluoromethanesulfonyl)imide (N1114 NTf2). This IL was chosen 
because the cation, trimethylbutylammonium, is a saturated quaternary ammonium ion and 
therefore should not be reactive with or coordinate with any metals. The anion 
bis(trifluoromethanesulfonyl)imide was chosen because it is also somewhat inert, helps make the 
ILs hydrophobic , and it facilitates synthesis.  
Technetium-99 (99Tc t1/2: 2.1×105 years; βmax: 293.7 keV) is a high-yield (6%) fission 
product in light-water reactors that presents major challenges in separations and containment 
technologies. As mentioned in Chapter 1, technetium-99 is a major contributor to the radiation 
dose from nuclear waste. Considering the complex technetium redox chemistry and varied 
speciation in the waste tanks, the storage of technetium with other nuclear waste is challenging. 
The current plan for dealing with the nuclear waste at Hanford is vitrification, which is the 
process of trapping materials in borosilicate glass. The vitrification process requires a large 
amount of heat in the presence of water. This process volatilizes technetium. Childs and others 
found that two technetium species form at these temperatures, HTcO4 and Tc2O7. Both of these 
compounds are volatile and they are likely the reason for the very low yields of technetium 
during vitrification 14. While vitrification is slated for the Hanford waste, it is of interest to find 
alternative methods of storing technetium for other applications. ILs have also been used to 
separate and electrodeposit metallic fission products. This study sought to establish a 
fundamental understanding of the behavior of technetium in ionic liquids in order to assess the 
feasibility of using ionic liquids for separations of nuclear waste.  
It has been shown that technetium can be extracted into ILs using crown ethers.107 In that 
study, crown ethers were used to extract NaTcO4 from an aqueous solution into the IL, 
trihexyltetradecylphosphonium bis(trifluoromethanesulfonyl)imide (P66614 NTf2). The 
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mechanism for the extraction of a salt in an IL can involve cation or anion exchange. Extraction 
via ion exchange is considered less desirable because it would eventually lead to the loss of the 
IL as the cations or anions are depleted. In this study, pertechnetate and its counter ion, Na+, 
were extracted into P66614 NTf2. This was accomplished with the help of a crown ether. This 
study showed that pertechnetate can be extracted into an IL while keeping the IL intact.  
Another study used IL constituents to extract technetium. Petrova and coworkers108 
utilized bifunctional ionic liquids to functionalize mesoporous silica. Imidazolium ILs with a 
silicate functional group on one of the alkyl chains were used to modify mesoporous silica beads. 
The modified beads were submerged into a solution containing TcO4- and various other anions. 
This study found that the “soft” ILs constituents, such as the imidazolium ion preferred the TcO4- 
ion over “hard” cations like chlorine, nitrate, bromine, iodine etc.  
One study observed that the extraction of technetium was influenced by the presence of 
acid109. That study utilized various ionic liquids that bear similarities to tributylphosphate (TBP), 
which is the common extractant for TcO4-. The study also examined the effect of various 
concentrations of nitric acid on the extraction. It was found that the best extraction was with 
methyltrioctylammonium bis(trifluoromethanesulfonyl)imide (N1888 NTF2). The extraction 
increased when 0.1 M nitric acid was added to the aqueous solution. However, as higher 
concentrations of acid were added, the extraction of TcO4- decreased. It was theorized that this is 
due to the formation of pertechnic acid. The actual speciation of technetium itself was not 
examined in this study and therefore remains unknown.  
While there are no known studies of the speciation of technetium in ILs, there has been 
some work on the speciation of technetium in aqueous acidic media. A study by Poineau110 
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demonstrated that is protonated at high concentrations of sulfuric acid technetium, meaning that 
the pertechnetate ion becomes pertechnic acid. In this work, 12 M sulfuric acid was added to an 
aqueous solution of KTcO4, it was found that the addition of 12 M sulfuric acid to the solution 
results in the formation of HTcO4. This species was determined using UV-Vis studies, EXAFS 
and DFT calculations. Other studies111 have found that this behavior is dependent on the acid. It 
was found that concentrated nitric acid (15 M) does not form pertechnic acid in aqueous 
solutions. 
Strong acids are often present in nuclear fuel waste separations. If ILs are to be used in 
the separation of technetium, it is important to study the behavior of technetium and acid in ionic 
liquids. The study reported here probes the speciation of technetium in ILs and acidified ILs 
using simple systems. The IL used is N1114 NTf2 and the acid used is HNTf2 which is the 
conjugate acid of the IL anion. This simple system allows for the study of the interaction of the 
TcO4- ion with a proton without the addition of a different anion with its own chemical behavior.  
4.2 Methods and Materials  
General considerations for handling technetium-99  
Technetium-99 is a weak beta emitter with a half-life of 2.1×105 years. All syntheses and 
handling of techenium-99 solids and solutions were conducted in a laboratory approved for 
manipulation of long lived radioactive materials.  
4.2.1 Materials  
Methyl iodide was obtained from Alfa Aesar. Dimethylbutylamine was obtained from 
Tokyo Chemical Industry. Lithium bis(trifluorormethanesulfonyl)imide was obtained from 
Acros Organics. Solid ammonium pertechnetate (NH4TcO4) was purchased from Oak Ridge 
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National Laboratory. Water was obtained using a Millipore Direct Q5 system (conductivity 18 
mΩ). Tetrabutylammonium bromide and tetrabutylammonium hexafluorophospate were 
purchased from Aldrich. The ionic liquid, trimethylbutylammonium 
bis(trifluoromethanesulfonyl)imide, which was used for X-ray Absorption Spectroscopy (XAS) 
studies, was obtained from Iolitec.  
4.2.2 Trimethylbutylammonium Iodide 
Methyl iodide, Alfa Aesar 99.5% (50 g, 0.35 mol) was added slowly to 
dimethylbutylamine (Tokyo Chemical Industry 99%) (36 g, 0.35 mol) in an ice bath while 
stirring. The resultant solid suspension was slowly brought up to room temperature and stirred 
overnight. The pale-yellow solid was isolated via vacuum filtration and dried under vacuum. The 
product was then dissolved in deionized water and 4 g (5% w/w) of activated charcoal was added 
to the solution. The solution was then heated to 65˚C for 24 hours, cooled to room temperature, 
and gravity filtered. The solution is rotary evaporated to yield a white solid. The structure of the 
salts was confirmed using 1H and 13C NMR. Yield 78 g, 0.32 mol 91% 
4.2.3 Trimethylbutylammonium bis(trifluoromethanesulfonyl)imide (N1114NTF2): 
Trimethylbuytlammonium iodide (42 g, 0.17 mol) is dissolved in DI water (40 ml) and 
one molar equivalent of lithium bis(trifluorormethanesulfonyl)imide (Acros Organics) was added 
to the stirring aqueous solution (50 g, 0.17 mol). The resultant IL was washed with deionized 
water to remove halide byproducts; the complete removal of halide is confirmed with  silver 
nitrate tests on the washings. The ionic liquid was dried using a vacuum oven for 2 days to 
achieve a water content under 200 ppm. Once dry, the IL was passed through activated alumina 
to ensure the removal of excess charcoal and other particulates. To ensure optical purity, a UV-
Vis spectrum was run on the IL to ensure that there was no absorbance in the UV-Vis range 
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(250-800 nm). The structure of the salt was confirmed using 1H and 13C NMR Yield 56 g, 0.14 
mol, 83% 
4.2.4 Ammonium Pertechnetate 
Solid ammonium pertechnetate (NH4TcO4) purchased from Oak Ridge National 
Laboratory is black in color. This is a result of contamination with TcO2 due to radiolytic auto-
reduction of NH4TcO4. The NH4TcO4 was regenerated and standardized before use by the 
following procedure.112 Briefly, 250-400 mg of the black compound was suspended in 1 to 2 ml 
of DI water. Hydrogen peroxide, 30%, 2-5 ml was added to the mixture. After 1-2 days at room 
temperature, the black solid dissolves and the solution becomes clear and colorless.  The solution 
was then heated to remove any excess peroxide and to reduce the volume by approximately half. 
The solution was then standardized: an aliquot of the aqueous NH4TcO4 solution was taken and 
dissolved in DI water. A UV-Vis spectrum of the solution was measured and using Beer’s law, 
the concentration was calculated using one of the two characteristic absorbance bands of the 
TcO4 anion, 247 nm and 289 nm, and their extinction coefficients 6200 and 2340 respectively. 
4.2.5 Tetrabutylammonium pertechnetate (TBA TcO4):  
In short, 100 mg of solid black NH4TcO4 was placed in a vessel along with 5 ml of DI 
water and 2 drops of concentrated hydrogen peroxide. The sample was then heated to 110˚C for 
15 minutes. The sample was then cooled and placed in a centrifuge tube. 280 mg of TBA(HSO4) 
was dissolved in 3 ml DI water and added to the tube. The resultant TBA TcO4 salt precipitates 
from the solution and was isolated via centrifugation. Once isolated, the salt is recrystallized 
using absolute ethanol.  
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4.2.6 TBA TcO4 IL solution preparation for X-ray Absorption Spectroscopy: EXAFS and 
XANES experiments  
Solutions were prepared by weighing HNTf2 (15-284 mg) into each of four 2 mL 
polypropylene centrifuge tubes then adding 0.75 mL of the IL (MeBu3N)(NTf2) to the tubes. The 
samples were sonicated until the HNTf2 was completely dissolved. To each tube 0.25 mL of 
(Bu4N)(TcO4) (0.14 M, 0.03 mmol Tc) was added to the IL. Samples quickly turned golden 
yellow, and slowly became orange, then red. The samples with higher concentrations of HNTf2 
changed color more quickly. The amount of HNTf2 in each sample is given in Table 4.1. vide 
infra. 
Note: the concentrations of TcO4- and HNTf2 used for the X-ray absorption spectroscopy 
studies are an order of magnitude higher than for the UV-Visible titrations of HNTf2 into 
TcO4- in the IL 
 
Table 4.1. Concentration of HNTf2 and TcO4-  in the XAS samples   
Sample HNTf2 (mg) [HNTf2] (M) [Tc] (mM) 
1494 15 0.05 34 
1495 25 0.09 34 
1496 125 0.44 34 
1497 284 1.01 34 
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4.2.7 NMR Experiments 
NMR Experiments were conducted on a Bruker 400 MHz NMR spectrometer with a 
multinuclear probe. IL NMR samples were prepared by dissolving approximately 10 mg of 
sample in 0.5 ml of D2O or DMSO.  
4.2.8 UV-VIS Titration 
The UV-Vis experiments were carried out on a Shimadzu UV-VIS spectrophotometer 
using quartz cuvettes. Aqueous UV-VIS titrations were performed by infusing an aqueous 
solution of NH4TcO4 with a solution of HNTf2 (aq). The IL titrations were carried out by a 
stepwise infusion of a TBA TcO4 /IL solution with a HNTF2/IL solution. The concentrations 
used for aqueous titrations were on the order of 0.133 mM TcO4- and 209 mM HNTf2. The 
concentrations used for UV-Vis titrations in the IL were 0.181 mM TcO4- and 215 mM HNTf2.  
As noted above, the concentrations for the UV-visible studies are about an order of magnitude 
lower than used for the XAS studies, which used 34 mM TcO4- and up to 1M HNTf2.  
EXAFS/XANES  
Tc K edge (21044 eV) EXAFS and XANES data were obtained by Dr. Wayne Lukens of 
Lawrence Berkeley National Laboratory at SSRL BL 11-2. The procedure for EXAFS and 
XANES studies were established by Lukens and published in 2017113and were conducted as 
follows.  The procedure is standard for technetium complexes and the following paragraph is 
quoted exactly from Chatterjee, reference 113.:  
“XANES data were obtained from 200 eV below the edge to 1000 eV above the 
edge; the data from 75 eV below the edge to 200 eV above the edge was obtained with 
0.5 eV spacing. The rest of the data points are widely spaced (50 eV) and were used for 
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the pre- and post-edge correction. EXAFS data was obtained with the same pre-edge 
energy spacing, and the spacing above the edge was obtained with a k-spacing of 0.05, 
and the collection time was weighted by k3. The monochromator was detuned 50% to 
reduce the harmonic content of the beam. Transmission data was obtained using Ar-filled 
ion chambers. Data were reduced from raw data to spectra using SixPack. Spectra were 
normalized using Artemis. Sample spectra were convolved with a 1.2 eV Gaussian to 
match the resolution of the standard spectra. Normalized XANES spectra were fit using 
standard spectra in the locally-written program "fites.'' XANES spectra were carefully 
energy calibrated using TcO4- adsorbed on Reillex-HPQ as the energy reference. The 
sample XANES spectra were allowed to vary in energy during fitting. The XANES 
spectral resolution is 7 eV based on the width of the TcO4- pre-edge peak, so each 
spectrum possesses 20 independent data points (range of the spectrum/resolution).” 
(Chatterjee 2017) 
EXAFS data were also obtained from the raw absorption data using Athena. Data were 
deglitched to remove a large glitch (4 data points were deleted). EXAFS data were fit using 
Artemis. Theoretical scattering factors were calculated using Feff6 using the crystal structure of 
[Ti(O,O’-NTf)(O-iPr)2]2(µ-O-iPr)2 with Tc replacing Ti and the isopropyl groups removed.114 
The data were fit using a combination of TcO4- and [Tc(O,O’-NTf)2]2(µ-O)2 based upon the 
structures of [Ti(O,O’-NTf)(O-iPr)2]2(µ-O-iPr)2 and [Tc(ox)2]2(µ-O)2 (ox = oxalate).115 The NTf2 
ligand coordinates to the Tc center via the sulfuryl oxygen groups, in analogy to the 
acetylacetonate anion. 
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4.3 Results and discussion 
4.3.1 Aqueous UV-VIS Studies: titration of NH4TcO4 with aqueous HNTf2 acid in water 
Pertechnetate, TcO4- [0.133 mM] in water shows two characteristic peaks in the UV-
Visible spectrum.  These are at 247 nm (ε 6200) and 287 nm (ε 2340).  Upon addition of an 
aqueous solution of HNTf2 [mM] in increments of 100:1 [HNTf2]:[TcO4-] stoichiometry. There 
is no significant change in the absorbance profile of the pertechnetate ion after the addition of 
HNTf2 (Figure 4.1). There seems to be a very small increase in the absorbance profile at 600 
molar equivalents (~80 mM of HNTf2), and there is also a small increase in the absorbance at 
290 nm peak. This may signify the onset of a reaction between the HNTf2 and the TcO4- anion 
but likely there is no reaction. A much larger concentration (12M) of aqueous HNTf2 acid was 
added to a solution of 0.173 mM NH4TcO4 (Figure 4.2). There is a small change in the 
absorbance spectra of the TcO4- at 290, but the there is no indication of protonation, which would 
be represented by an absorbance at 330 nm. It is clear that in water HNTf2 is “leveled” to the 
hydronium ion, which lacks the acidity to protonate TcO4-. 
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Figure 4.1.Titration of Aqueous NH4TcO4 with HNTf2 
	
Figure 4.2. UV-Vis spectrum of aqueous solutions of NH4TcO4 (black trace) and NH4TcO4 with 12M HNTf2 (red trace) 
	
4.3.2 Ionic Liquid UV-Vis Studies:  Titration of NH4TcO4 with HNTf2 acid in 
trimethybutylammonium bistriflimide 
In this study, pertechnetate was titrated with HNTf2 in trimethybutylammonium 
bistriflimide (N1114 NTf2) and monitored by UV-Visible spectroscopy. This experiment was 
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performed to test the reactivity of TcO4- in ionic liquids. A 0.181 mM solution of TBA TcO4 in 
the dry IL (water content <400 ppm) was titrated using a 215 mM HNTf2/IL solution in 
increments of 100 (84 µl) molar equivalents. After the first addition of acid (100 eq), (Figure 
4.3) a shift in absorbance from 290 nm to 308 nm was observed, which suggests a reaction 
between the HNTf2 and the TcO4-. After the second 100 eq. addition of HNTf2 acid, absorbance 
of the species shifts from 308 nm to 330 nm. After 300 equivalents, the absorbance seems to 
remain constant. Previous work by Poineau et al110 observed formation of a species with a peak 
at 330 nm. The absorbance feature at 330 is assigned to pertechnic acid (HTcO4). In that work, 
the formation of pertechnic acid was achieved at 9M sulfuric acid.  In the ionic liquid, if this 330 
nm peak represents HTcO4, the HTcO4 is being formed at roughly 20 mM of HNTf2 acid.  
 
Figure 4.3. UV-Vis titration of TBA TcO4  in trimethybutylammonium bistriflimide (N1114 NTf2) 
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4.3.3 Effect of Water Content 
The shift in the UV-Visible spectrum from 290 nm to 330 nm upon titration of TcO4- with 
~20 mM of HNTf2 in a dry ionic liquid is consistent with protonation to form HTcO4. Figure 4.4 
shows two spectra of TBA TcO4 dissolved in a wet N1114 NTf2. The N1114 NTf2 was left on the 
benchtop for 24 hours, and Karl Fischer titration determined that the water content of the IL was 
greater than 1000 ppm. The red trace shows 0.2 mM TcO4- in the IL and the blue trace shows the 
solution with 600 molar equivalents of HNTf2 acid added. The characteristic absorbances of 
TcO4– (290 nm and 244 nm) are present in the solution without acid. We postulate that given the 
amount of acid added to the solution (120 mM), HTcO4 should be formed, and it would be 
observed by an absorption band at 330 nm. The UV-visible spectrum shows a very broad 
absorbance from 240 nm to 400 nm that may encompass the 330 nm peak, but the underlying 
bands are not clearly defined. This broad absorption difficult makes it impossible to determine 
which species are formed in the solution. We speculate that an incomplete protonation of TcO4-  
may be occurring. The incomplete protonation can be due to competition between the formation 
of hydronium (H3O+) and the formation of HTcO4 in solution.  
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Figure 4.4. UV-Vis spectra of 0.2m M TBA TcO4 in wet N1114 NTf2 and 0.2 mM TBA TcO4 with 600 molar equivalents 
of HNTf2 in wet N1114 NTf2 water content >1000) 
4.3.4 X-ray Absorption Spectroscopy  
4.3.4.1 X-ray absorption near edge structure (XANES)  
In an effort to identify the species formed during the titration, Extended X-Ray Absorption 
Fine Structure (EXAFS) and X-ray Absorption Near Edge Structure (XANES) studies were 
conducted. As previously mentioned, the EXAFS and XANES studies were executed and 
analayzed by Wayne Lukens the exact method for analyzing the data was reported by 
Chatterjee113. The analysis is standard for technetium complexes and the following paragraph is 
quoted exactly from Chatterjee, reference 113.   
“Five standard spectra were used to fit in the initial fitting of the sample XANES 
spectra: TcVIIO4-, TcV polyoxometalate, TcIVO2•2H2O, TcIV gluconate, and Tc(IV) EDTA 
complex. TcV polyoxometalate is actually a sample of TBA4-xHx TcOPW11O39 as this 
provides a clean TcV standard for XANES. The latter three standards represent TcIV with 
varying degrees of disorder in the first shell of 6 oxygen atoms. In TcIV gluconate, the first 
shell consists of 6 oxygen atoms that are 2.0 Å from the technetium center in an octahedral 
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geometry. In TcO2•2H2O, there are 4 oxygen atoms located 2.0 Å from the technetium 
center and two oxygen atoms at a longer distance, ~2.4 Å. In TcIV EDTA, the first shell is 
quite distorted with two oxygen atoms at 2 Å, two oxygen atoms at a somewhat longer 
distance, and two nitrogen atoms still further away. These changes in the local environment 
of technetium produce changes in the shape of the Tc K-edge XANES spectrum as 
illustrated in Figure 4.5. The unknown Tc-XANES spectra were fit in the following way. 
Initially, all five standard spectra were used to fit each spectrum. Any non-pertechnetate 
standard spectrum for which the contribution was less than two standard deviations was 
removed, and the fitting process was repeated until TcO4- and a single TcIV standard 
remained. In these samples, only TcO2•xH2O contributed significantly. The purpose of 
removing the TcIV spectra that are not significant is to determine accurate standard 
deviations for the amount of TcIV in the sample. If more than one TcIV standard is used, the 
standard deviation of each becomes very large since their contributions are strongly 
correlated.”  
In other words, the spectra of all of the TcIV species are similar, so it is difficult to precisely 
determine how much of each TcIV standard is present in any sample. The fact that the TcIV 
EDTA standard spectrum fit the data well does not necessarily mean that the samples contain 
Tc(IV) EDTA. Rather the fact that the TcIV EDTA reference spectrum fits well means that the 
technetium environment in the sample resembles the Tc2(µ-O)2 dimeric structure of 
TcIVEDTA.116 
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Figure 4.5. Tc K-edge XANES spectra of the reference compounds used for XANES fitting.  
 
4.3.4.2 Fitting results  
The initial results for the XANES fitting are given in Table 4.2, and Figures 4.6-4.9. The 
TcIV standard that best fits the data is TcIVO2•2H2O. The only other significant contributor to the 
spectra was TcO4-. Unfortunately, TcVIIO4- and TcO2•xH2O do not accurately fit the spectra of 
technetium in samples with high concentrations of HNTf2. In other words, the technetium 
species in these samples does not have a local structure similar to any of the standard spectra. 
This has two implications. First, it is impossible to say much about the non-pertechnetate species 
other than it is not the tetrahedral pertechnetate anion. It could be octahedral TcVII, although this 
is unlikely, or it could be TcV or TcIV. The latter is suspected based on the color of the sample 
(dark red), which is reminiscent of the δ to δ* transition in the Tc2(µ-O)2 core of TcIV dimers. 
However, the XANES results neither support nor rule out any of these possibilities. Second, the 
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From top to bottom, these are the Tc K-edge spectra of Tc2S7 (a), Tc(IV) EDTA (b), 
TcO2•2H2O (c), Tc(IV) gluconate (d), PW11Tc=O (e), TcO4- (f). 
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lack of an appropriate standard for the non-pertechnetate species increases the uncertainty in the 
concentrations of the technetium species in these samples. The results of these fits cannot be 
interpreted quantitatively.  
Qualitatively, these fits say that another species is being formed in the samples and the 
concentration of this species increases with increasing concentration of HNTf2. 
Table 4.2. Tc K-edge XANES results  
 
 
 
 
 
 
 
file TcO4- p Tc(IV) p 
1494 (34mM Tc 0.05 M HNTf2) 0.65(2) <0.001 0.35(1) <0.001 
1495(34mM Tc 0.09 M HNTf2) 0.59(2) <0.001 0.41(2) <0.001 
1496(34mM Tc 0.44 M HNTf2) 0.45(4) <0.001 0.55(3) <0.001 
1497(34mM Tc 1.01 M HNTf2) 0.40(5) <0.001 0.60(4) <0.001 
Table 4.2 Tc K-edge XANES results – (not quantitative due to poor fit to data) Standard deviation of the fit is 
given in parentheses. The value of p is the probability that the improvement to the fit from including this spectrum 
is due to random error. Co Components with p < 0.05 are significant at the two-sigma level and those with p < 
0.01 are significant at the 3 sigma level 
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Figure 4.6. Tc K-edge XANES spectrum of 1494 (34mM TcO4-, 50 mM HNTf2) and fit using TcO4- and TcO2•xH2O as 
standards 
 
Figure 4.7. Tc K-edge XANES spectrum of 1495 (34mM TcO4-, 90mM HNTf2) and fit using TcO4- and TcO2•xH2O as 
standards 
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Figure 4.8. Tc K-edge XANES spectrum of 1496 (34mM TcO4-, 440 mM HNTf2) and fit using TcO4- and TcO2•xH2O 
as standards 
 
 
Figure 4.9. Tc K-edge XANES spectrum of 1497 (34mM TcO4-, 1 M HNTf2) and fit using TcO4- and TcO2•xH2O as 
standards 
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Due to the uncertainty in the concentration of TcO4- and non-pertechnetate species in 
these samples, the data was modeled using the spectrum of the sample with 1M HNTf2 (1497) as 
the standard rather than the spectrum of TcO2•xH2O. This approach results in excellent fits to the 
data Figures 4.10-4.12. Note that the results of this approach do not yield the actual 
concentrations of any species. Rather, this approach produces the difference in TcO4- 
concentration between the spectrum being fit and that in sample 1497. The results are given in 
Table 4.3.  
Table 4.3. Tc K-edge XANES results using 1497 as a standard.  
Sample Δ TcO4-b p 1497 p 
1494 0.42(2) <0.001 0.58(2) <0.001 
1495 0.33(2) <0.001 0.67(2) <0.001 
1496 0.09(1) <0.001 0.91(1) <0.001 
 
 
 
 
XANES spectroscopy of this series of samples clearly reveals that an additional species is 
present, and its concentration is correlated with the amount of HNTf2. The oxidation state and 
local environment of this species is not similar to any of the standard spectra (Figure 4.5), which 
means that the absolute speciation of Tc in this sample cannot be determined quantitatively. 
However, the relative concentration of TcO4- in these samples may be determined quantitatively 
using the spectrum of the sample with the highest concentration of HNTf2 as a reference 
spectrum.  
Table 4.3 Standard deviation of the fit is given in parentheses. The value of p is the probability that the 
improvement to the fit from including this spectrum is due to random error. Components with p < 0.05 are 
significant at the two-sigma level and those with p < 0.01 are significant at the 3 sigma level. Δ TcO4- is the 
difference in TcO4- concentration between the sample and that in sample 1497 
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Figure 4.10. Tc K-edge XANES spectrum of 1494 (34mM TcO4-, 50 mM HNTf2 and fit using TcO4- and 1497 as 
standards) 
 
Figure 4.11. Tc K-edge XANES spectrum of 1495 (34mM TcO4-, 90 mM HNTf2 and fit using TcO4- and 1497 as 
standards) 
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Figure 4.12. Tc K-edge XANES spectrum of 1496 (34mM TcO4-, 440 mM HNTf2 and fit using TcO4- and 1497 as 
standards 
 
4.3.4.3 Extended X-ray Absorption Fine Structure (EXAFS) 
The fine structures of the EXAFS are very weak for reasons discussed below (Figure 
4.13). The data were modeled as a mixture of TcO4- and a TcIV dimer similar to [Tc(ox)2]2(µ-O)2 
or [Tc(EDTA)]2(µ-O)2 consisting of two technetium centers bridged by two oxygen atoms.115, 117-
119 In addition, each technetium has two oxygen bound NTf2 ligands filling out the technetium 
coordination sphere. The number of neighboring atoms was not allowed to vary individually; 
instead, the spectra were fit using a combination of TcO4- and TcIV dimer. The EXAFS fit 
parameters are given in Table 4.4.  The coordination numbers were calculated using the fraction 
of technetium that was present as TcIV (or TcO4-). In the TcIV dimer, the number of neighboring 
atoms in the scattering shells are 2 bridging oxygen atoms at ~1.75 Å, 4 oxygen atoms from the 
(O,O’-NTf2) ligands at 2.03 Å, 1 Tc neighbor at 3.11 Å, 4 sulfur atoms from the (O,O’-NTf2) 
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ligands at 3.38 Å, and 4 oxygen and 2 nitrogen atoms (fitted as six oxygen atoms) in the (O,O’-
NTf2) ligands at 3.9 Å. The distances are similar to those found in the structure of [Ti(O,O’-
NTf)(O-iPr)2]2(µ-O-iPr)2114, which is unsurprising given the similar ionic radii of TcIV and TiIV 
120 Moreover, the low p-values of the scattering shells means that, apart from the Tc shell at 3.11 
Å, the scattering shells contribute significantly to the EXAFS model (improvement to the fit is 
greater than 2 s). The EXAFS spectrum is consistent with the presence of a mixture of TcO4- and 
[Tc(O,O’-NTf)2]2(µ-O)2. In addition, the color of the solution is consistent with the presence of a 
TcIV dimer (Figure 4.14), which are characterized by a strong absorption at 20000 cm-1 (500 
nm).117, 119  
As noted above, the EXAFS of this sample are very weak. This is due largely to the 
destructive interference among the Tc-O scattering shells at 1.63, 1.76, and 2.03 Å, which make 
the scattering from the closest oxygen shells weak. The same behavior is seen in the EXAFS 
spectrum of [Tc(EDTA)]2(µ-O)2. The amount of TcIV in the sample is 59 (6)% as determined by 
EXAFS. This may be compared with the amount that is more accurately determined by XANES 
60 (4)%. The agreement maybe somewhat fortuitous, EXAFS is not particularly accurate at 
determining quantitative speciation due to the strong correlation between the coordination 
numbers and the Debye-Waller parameters. The only scattering shell that does not contribute 
significantly to the model is the Tc shell at 3.11 Å. It is possible that Tc TcIV in this sample is a 
mixture of [Tc(O,O’-NTf)2]2(µ-O)2 and Tc(O,O’-NTf)3 as previously observed for TcIV in 1,2-
diols.  
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Figure 4.13. Tc K-edge EXAFS spectrum of Tc (red) and fit (black) (left panel) and its Fourier transform (right panel). 
 
Figure 4.14. Proposed technetium dimer structure 
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Table 4.4. EXAFS fit Parameters 
Neighbor # of Neighbors Distance (Å) σ2 (Å2)   [Ti(NTf)(O-iPr)2]2(µ-O-iPr)2 
O 1.6(2)b 1.633(8) 0.001c 0.004 TcO4-: 4 O @ 1.73 Å 
bridging-O 1.2(1)b 1.76(1) 0.0034(7) <0.001 2 O @ 1.75 Å 
S-O 2.4(2)b 2.029(5) 0.0034(7)d <0.001 2 O @ 2.20 Å 
Tc 0.6(1)b 3.11(2) 0.006(2) 0.055 1 Ti @ 3.18 Å 
S 2.4(2)b 3.38(1) 0.0031(7)d <0.001 2 S @ 3.38 Å 
O 3.5(3)b 3.73(2) 0.0031(7)d 0.023 3 O @ 3.58 to 4.14 Å 
O-Tc-O-Tc (MS) 3.5(3)c 3.87(7) 0.0034(7)e 0.001 6 @ 3.88 Å 
 
a) S02 = 0.9 (fixed),  E = -9(1) eV; fit range 3<k<14.1; 1<R<3.7; # of independent points: 21.4; # of 
parameters: 12, r_factor 0.012; standard deviations are given in parentheses and are in the same 
units as the last digit. 
b) Fraction Tc(IV) = 0.59(6) 
c) Parameter fixed 
d) Parameter constrained to vary with preceding parameter 
e) Parameter constrained to vary with the Debye-Waller parameter of the Tc-O shell at 2.07 Å 
 
4.4 Conclusion and Future Work 
TcO4- is very reactive towards HNTf2 in the dry ionic liquid (N1114 NTf2). Compared to 
the study by Poineau6 where a shift of the characteristic TcO4- UV band from 280 nm to 330 nm 
is observed upon addition of 9 M H2SO4 to approximately 100 mM TcO4- in water, we observed 
a similar shift with 20 mM HNTf2 with 0.181 mM TcO4- in the ionic liquid 
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trimethybutylammonium bistriflimide (N1114 NTf2). If this shift is due to protonation of TcO4-, 
we can speculate that technetium is protonated at much lower concentrations of acid in the IL 
than in aqueous media. Our studies where HNTf2 is titrated into TcO4- under aqueous conditions 
suggest that TcO4- will not be protonated even at high concentrations of HNTf2 (12M) in water. 
The HNTf2 acts as a very strong acid in the ionic liquid but its acidity is “leveled” in water and 
therefore does not posess sufficient acid strength to protonate TcO4-.  
The NTf2- anion of trimethybutylammonium bistriflimide (N1114 NTf2) ionic liquid is 
considered inert.  However, we find that in the HNTf2/(N1114 NTf2) ionic liquid system in 
combination with TcO4- renders the NTf2- anion able to reduce and coordinate to the reduced 
technetium.  The XANES data are consistent with the formation of a technetium µ-oxo dimer 
(TcIV(µ-O)2TcIV). The EXAFS data is also consistent with formation of a µ-oxo dimer formed 
with two technetium ions and with the anion of the IL. The coordination with the anion is not 
formed through the negatively charged nitrogen. Rather, it is formed through the oxygens of the 
sulfate group. It appears that the anion of the IL was oxidized during the reduction of TcO4-.   
 Future studies need to be performed to explicitly determine the speciation of the 
technetium in the solutions. For example, the UV-Visible titrations were conducted at millimolar 
concentrations of TcO4- and HNTf2 whereas the X-ray Absorption Spectroscopy was conducted 
using molar quantities of TcO4- and HNTf2 this implies that the formation of the dimer may be 
acid concentration or time dependent. Performing UV-Vis and XAS using comparable 
concentrations (both high concentrations and low concentrations of TcO4- and HNTf2) will be 
important to tie in the speciation. There was a time difference between the preparation of the 
XAS samples at Lawrence Berkeley National Laboratory and the actual executions of the 
experiments at the synchrotron. If it would be possible to shorten the time interval between 
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sample preparation and conducting the EXAFS and XANES experiments, that may provide data 
that is directly comparable with the UV Visible experiments that are run immediately. 
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5. Electrochemical Studies of Standard Technetium 
Complexes in an Ionic Liquid 
5.1 Introduction 
The use of ionic liquids in the nuclear fuel cycle has been probed for the past few years, 
the most common application being extraction and separation of metal fission products of U-
235.121-132 In addition to extraction, the electrodeposition of fission products has been 
investigated. Hussey et al15 successfully extracted and deposited a nuclear fission product, 
strontium, using ILs. The deposition of metallic fission products can be advantageous for the 
long-term storage of long lived isotopes such as technetium-99. Technetium has a wide range of 
oxidation states (-1 to +7), which along with the long half-life of 99Tc (2.1×105 years) can 
complicate long term storage strategies. It has been previously shown that technetium can be 
extracted into ILs,107, 109 however since the electrochemical behavior of technetium has never 
been studied in ionic liquids, it is of interest to see if technetium can be reduced in ILs as well. 
Technetium is a group 7 metal that has never been isolated as a bare ion in solution, and though 
the electrodeposition of technetium is not as straightforward as the reduction of other fission 
products such as the aforementioned strontium, it is still possible. It is important to study the 
effects of ILs on the redox behavior of technetium as ILs have been shown to shift the redox 
potential of metals in the positive direction.133-134 The fundamental electrochemistry of 
technetium in ILs must be investigated in order to ascertain the feasibility of using them to 
address the technetium storage problem. 
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An attractive waste form for the storage of technetium is the pure metal, since metallic 
technetium is known to be robust and not easily oxidized. Storage in the metal form requires the 
complete reduction of technetium-99, which can occur in one of two ways: chemical reduction or 
electrodeposition. The chemical reduction of technetium is not practical for large scale 
processing due to the use of flammable hydrogen gas and the elevated temperatures for the 
reaction. The standard potentials for reduction of technetium to the metal show that it does not 
require very high potentials; the standard electrode potential for the reduction to the Tc0 is -0.48 
V. Theoretically, electrochemical reduction of technetium should not be difficult. In practice 
however, the electrochemical deposition of technetium in aqueous media is quite difficult, as it 
requires a high concentration of acid and it is still inefficient, with only about 25% of technetium 
being plated out of solution.135 As shown in Equation 3. 
Equation 3. Aqueous reduction of pertechnetate 
TcO4− (aq) + 7e− + 8H+ −−−→Tc(s) + 4H2O   Eo-0.477 V 
 
 TcO4- however, can also be reduced to TcO2 in the form of the solid insoluble compound 
TcO2•2H2O which is not easily reduced to metallic technetium. The formation of stable insoluble 
TcO2 hinders the process of electrodeposition of pure technetium metal. The electrochemical 
deposition of technetium in aqueous media also generates hydrogen gas, which makes large scale 
deposition both hazardous and impractical.  
In order to utilize technetium metal as a long-term storage waste form, alternative 
methods of electrodeposition must be investigated, since technetium has only been 
electrochemically reduced in aqueous media (acidic or basic) thus far. The reduction of a metal 
oxide in an oxygen-rich solvent may be one of the causes of its inefficiency.  Studies in organic 
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media show only a partial reduction of technetium from TcVII to a TcV complex; this may be due 
to the lack of available protons and the inability to support lower oxidation states.136 
 ILs are attractive media for electrochemical studies as they are salts and can be used as 
both the solvent and supporting electrolyte. Ionic liquids also tend to have low vapor pressure, 
high thermal stability, and wide electrochemical windows. Electrochemical studies in ILs have 
shown that redox processes tend to be shifted towards positive potentials meaning that reduction 
is facilitated. This may bode well for plating reduced or metallic Tc.137 ILs (both hydrophilic and 
hydrophobic) have been used to plate metals from solution.138 In order to investigate the 
potential use of ILs for electroplating technetium, we first set out to familiarize ourselves with 
the redox processes of technetium and its complexes in ILs and compare them to common 
organic electrochemistry solvent systems such as tetrabutylammonium hexafluorophosphate in 
acetonitrile.  
Technetium polyoxometalate complexes were also studied to ascertain the behavior of 
large, complex species in ILs. Polyoxometalate (POM) is the generic name given to large 
polyatomic anion transition metal oxide clusters consisting of early transition metals. These 
compounds are usually made up of highly oxidized metals from group 5 or 6 bound to multiple 
oxygen atoms. POMs were introduced in chapter 2. Within the larger family of POMs, there is a 
subcategory that share a specific Keggin structure with the formula H3PM12O40 where M can be 
tungsten, molybdenum, or other metals. Furthermore, some POMS can be modified or 
intentionally built with defects and coordinated to a metal. The POM used in this work, 
[PW11O39]7-, is a tungsten-based Keggin POM with a single defect site. Previous work139 has 
shown this particular POM to successfully coordinate Tc-oxo and Tc-nitrido cores. Technetium 
complexes with halide ligands, namely TcVOCl4- and TcVINCl4-, tend to be labile and prone to 
 110 
disproportionation to TcVIIO4- and TcIVO2 in the presence of water. Our previous studies in 
aqueous solutions have shown that once coordinated to a POM, the technetium undergoes 
reversible redox processes where transitions to the +4, +5. +6, and +7 oxidation states have been 
observed.140-141 Examination of the electrochemistry of these Tc=O and Tc≡N POM species in 
ILs will help elucidate whether the behavior of larger Tc species is affected by the change in 
solvent.  
The purpose of this work is to examine the redox chemistry of known technetium 
complexes in ILs and compare that behavior to the behavior in standard organic solvent systems. 
The ligands as well as the oxidation states were varied for this experiment. The technetium 
compounds studied range from TcVIIO4-, simple Tc complexes like TcVINCl4- or TcVOCl4-, to 
more intricate systems like TcV and TcVI -Keggin POM complexes. 
5.2 Experimental 
The general considerations for handling technetium-99 were described in section 4.2  
5.2.1 Materials  
Trimethylbutylammonum iodide and trimethylbutylammonium 
bis(Trifluoromethanesulfonyl)imide were prepared as described in sections 4.2.2 and 4.2.3. In 
addition, the IL for technetium metal dissolution, trimethylbutylammonium 
bis(trifluoromethanesulfonyl)imide, was obtained from Solvionic. 
 111 
5.2.2 Technetium Complexes  
Ammonium pertechnetate and tetrabutylammonium pertechnetate were prepared as 
described in sections 4.2.4 and 4.2.5 
5.2.3.3 Tetrabutylammonium tetrachlorooxotechnetate (TBA TcOCl4)142  
 TBA TcOCl4 was prepared according to established procedures. Briefly, 32 ml of 12 M 
HCl is added to 4 ml (0.32 M) of standardized aqueous solution of NH4TcO4 while stirring. After 
10 minutes, A 75% w/w solution of tetrabutylammonium chloride solution is added dropwise to 
the solution. The resultant green power is isolated via vacuum filter and washed repeatedly with 
12 M HCl followed by isopropyl alcohol. The solid is then dried under vacuum. The yield based 
on NH4TcO4 is 99% 
5.2.3.4 Tetrabutylammonium technetiumnitridotetrachloride (TBA TcNCl4)143  
Ammonium pertechnetate (63 mg, 0.35 mmol) was mixed with concentrated HCl (20 
mL). Sodium azide (200 mg, 3.1 mmol) was dissolved in water (0.5 mL) and carefully added to 
the pertechnetate solution. The solution turns orange with the evolution of gas. The solution is 
then heated under reflux for 20 minutes. TBAOH (0.42 mmol) is added to produce an orange 
precipitate (yield 95% based upon Tc). The solid was dissolved in acetonitrile (ACN) (3 mL) and 
diethyl ether added (20 mL). Cooling the solution to 5˚C causes orange crystals to form which 
are collected by filtration.  
5.2.3.5 [(N-CH4H9) N]4[PW11TcO40] (TBA TcO-POM)  
This compound was prepared using the Abrams method.139 TBA TcOCl4 (100 mg 0.2 mmol) was 
dissolved in 2 ml of ACN and added to a solution of TBA3 PW11O39 (0.6 g, 0.19 mmol in 5 ml of ACN). 
The sample is then filtered to remove any undissolved solids and layered with diethyl ether and allowed 
to stand for 2 days. The resultant crystals are washed with methanol.   
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5.2.3.6 [(N-CH4H9)N]3[PW11TcNO39] (TBA TcN-POM)  
This compound was prepared using the Abrams method.139 A solution of TBA TcNCl4 (60 mg, 
0.12 mmol) was dissolved in acetonitrile and added to a solution of TBA3 PW11O39 (0.37 g, 0.10 mmol in 
10 ml ACN). The solution was filtered and left to stand for 5 days. The subsequent dark crystals were 
isolated and characterized using IR spectroscopy.  
5.2.4 Technetium Metal Electrode 
A technetium electrode was prepared by pressing Tc0 metal powder (200 mg, 0.002 mol) 
with a 3 mm die (4 tons for 15 mins) the pellet was then arc melted to purify. The bead was 
flattened and mounted on a copper wire with silver epoxy. The electrode was then set in a 
Teflon® casing using an epoxy resin for 24 hours. After settling, the electrode was washed and 
polished. 
5.2.5 Electrochemistry  
There were four solvent systems studied: The IL, [N1114NTf2], the standard organic 
solution for electrochemistry [0.1 M TBAPF6/ACN], ACN (a coordinating solvent) using the IL 
as the supporting electrolyte, [0.1M N1114NTf2 in ACN], and dichloromethane with a non-
coordinating electrolyte, [0.1 M TBAPF6 in CH2Cl2]. Electrochemical experiments were 
conducted using a BASi Voltammetric Analyzer System controlled by BASi CV-50W software. 
The electrochemical cell was comprised of three electrodes: a glassy-carbon working electrode 
(3mm) (BASi MF-2012), a Pt wire auxiliary electrode, and a non-aqueous reference electrode 
(BASi MF-2062). All the CVs were referenced against the ferrocene redox couple. For ionic 
liquid studies, the silver wire was placed in the neat ionic liquid separated from the bulk solution 
using a glass sheath and a Vycor® frit. The frit sat in the neat IL under vacuum for 48 hours to 
ensure saturation with the ionic liquid. For ACN and dichloromethane (DCM), a 0.01M solution 
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of AgNO3 was made using the supporting electrolyte solution. Prior to data collection, solutions 
were purged with high-purity nitrogen gas. The TBA PF6/ACN solutions were degassed for at 
least 30 mins and the IL samples were degassed for at least 12 hours. Unless otherwise noted, 
scan rates were 100 mVs−1 and all experiments were carried out at ambient temperature under 
N2(g) Electrochemical studies of POMs in ILs were performed using a modified version of drop 
casting where the TcPOM complex is ground and adhered to the surface of an electrode.144 This 
procedure will be discussed later in the chapter. 
5.3 Results and Discussion 
5.3.1 Cyclic Voltammetry studies of technetium complexes in N1114 NTf2 
Figure 5.1 shows the CV was run on the neat IL to study the size of the electrochemical 
window and to ensure the IL was electrochemically pure. The measured electrochemical window 
is 3.9V (-2.3V to 1.8V), which was much larger than the window for TBA PF6/ACN (-1.7 IL V 
to 1.2 V, 2.9 V.). Having a large window enables us to view redox processes which otherwise 
could not be observed. The wide electrochemical window is also an indication of the purity and 
dryness of the IL. The electrochemical window decreases as the water content increases. There is 
a small feature in voltammogram at around 1.2 volts. This is believed to be the result of trace 
amounts of dissolved oxygen in the IL.  
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Figure 5.1. Cyclic voltammogram of N1114 NTf2 under nitrogen and referenced to ferrocene (Fc) 
 
5.3.1.1 TBA TcO4 in dry N1114 NTf2   
The CV of 1.3 mM TBA TcO4 in the dry IL is essentially featureless (see figure 5.2); 
there are no observable oxidation or reduction curves in the CV. There are no oxidation curves as 
technetium is already in its highest oxidation state as the pertechnetate ion. (TcVIIO4-). There are 
very small features in the voltammogram near 1.2 V and 1.8 V respectively, we believe that 
these features are the result or residual dissolved oxygen in the system Figure 5.1 vide supra 
also has small features in this region. These features are not believed to be due to the reduction 
of pertechnetate since the IL is dry (<200 ppm H2O). In a dry IL, there are no available protons 
to facilitate the reduction of pertechnetate.  
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Figure 5.2. CV of TBA TcO4 (2 mg,1.3 mM) in dry IL 
5.3.1.2 TBA TcO4 in wet N1114 NTf2   
In the wet IL, the CV shows several oxidations and reductions, which have yet to be 
identified (Figure 5.3). In this experiment, TBA TcO4 was dissolved in an IL that had a water 
content of approximately 1000 ppm. The IL was contacted (spiked) with 1 ml DI water, stirred 
and allowed to equilibrate. There is a large reduction wave at -500 which could correspond to a 
+7 to +6 reduction or a +7 to +4 reduction. Electrolysis will need to be performed to determine 
speciation. There is also a very sharp peak at -1500 mV, which may be the plating of TcO2 or the 
end of the solvent window of the ionic liquid.  
Scan direction 
100 mV/Sec 
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Figure 5.3.CV of TBA TcO4 in a wet IL (blue trace) and a dry IL (red trace) 
 
5.3.1.3 Tetrabutylammonium tetrachloronitridotechnetate (TBA TcNCl4)  
Tetrabutylammonium tetrachloronitridotechnetate is a known complex of technetium. 
This compound exhibits relatively high stability because of the nitrido (N3-) ligand, a strong pi 
electron donor known for stabilizing high-valent metals145 that  makes a triple bond with 
technetium. Unlike other technetium complexes that are very reactive and display irreversible 
oxidations/reductions the stability of the nitrido complex makes it an attractive candidate for 
electrochemical studies. The redox chemistry of this compound was studied in all four organic 
systems 0.1M TBA PF6/ACN, N1114 NTf2, 0.1 M N1114 NTf2/ACN, and 0.1M TBA PF6/CH2Cl2 
(Figure 5.4). In the TBA PF6/ACN solvent system (Figure 5.4C), there is a quasi-reversible 
redox wave at –0.19 V, which is believed to the be the 5/6 redox couple. In the N1114 NTf2/ACN 
system (Figure 5.4B), there is also a quasi-reversible redox couple that occurs at -0.16. In both 
ACN systems, two additional oxidation peaks are observed. This may be due to the acetonitrile 
complexing with [TcNCl4-]. In the TBAPF6/CH2Cl2 solvent system (Figure 5.4A), there is a 
Scan direction 
100 mV/Sec 
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reversible redox wave which occurs at -252 mV. It is likely that the redox process in this system 
is reversible because the solvent does not coordinate to the complex. In the IL, the 5/6 couple 
occurs at 86 mV. This shows promise towards plating technetium in ionic liquids; if the 
reduction of this compound is facilitated by the IL perhaps the reduction to the metal will be 
facilitated as well.145-146 In our experiments, we have found that the redox potential of the 5/6 
couple in the N1114 NTf2/ACN system is very similar to the TBAPF6/ACN system. The 5/6 
couple shifted by only +37 mV in the solution using the IL as the supporting electrolyte. This 
shows that the effect of the ionic liquid is a property of the bulk material rather than the cation 
and anion.  
 
Figure 5.4.Voltammograms of 2 mM TBA TcNCl4 in different solvent systems: DCM (A), TBA PF6/ACN (B), IL (C) and 
N1114 NTf2/ACN (D) 
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5.3.1.4 Polyoxometalates 
Figure 5.5 shows the redox behavior of the [TcO]3+(left) and [TcN]4+(right) cores 
coordinated to the [PW11O39]7- POM respectively. It also shows the redox processes of the 
tungsten atoms contained within the polyoxometalate framework. The study of polyoxometalate 
redox chemistry in ionic liquids is challenging due to the low solubility of the POM in ILs and 
poor mass transport, which make it difficult to get enough POM into the IL to study using CV. 
To overcome this challenge, a modified version of drop casting was employed to study the Tc-
POM salts in the ionic liquids. The Tc-POM complexes were ground into a powder that was 
adhered to the surface of a freshly polished glassy carbon by rubbing the electrode on a filter 
paper with the ground compound on it. This method was previously described by Zhang.144 
When a voltage is applied to an electrode with a POM adhered to it, an electron is transferred to 
the POM, which promotes the dissolution of solid POM. When adhered to the electrode, the 
POMs exhibit the same electrochemical behavior as dissolved POMs the signals are larger but 
are more defined144 than they would be if they were simply dissolved in the IL because of the 
high local concentration near the working electrode.  
TBA TcO-PW11O39 and TBA TcN-PW11O39 complexes were studied in an organic 
solvent (0.1 M TBA PF6 in ACN) and in N1114 NTf2. In both compounds, the redox potential of 
the POM and the redox potential of the technetium couples in the IL are shifted in the positive 
direction Table 5.1. In the TcO-POM, the 4/5 couple shifts from -1.1 V to -587 mV, the 5/6 
couple shifts from 0.45 V to 0.63 V, and the 6/7 couple shifts from 1.35 V to 1.38 V, in the TcN-
POM, the 5/6 couple shifts from 0.45 to 0.63 V and the 6/7 couple shifts from 0.85 to 1.07. This 
shows that the reduction of technetium in both compounds is facilitated by the ionic liquid. The 
reduction of tungsten is also facilitated in ILs, there is an additional redox wave observed in the  
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 IL system. This wave centered at -1300 mV for both systems is likely to originate from 
W redox within the POM. To unambiguously assign the redox waves, spectroelectrochemistry 
would need to be performed and unfortunately that work is outside the scope of this study. 
 
Figure 5.5. Voltammograms of TBA TcO-PW11O39  
 
 
 
Table 5.1. Measured redox properties of Tc complexes against ferrocene 
Compound Solvent POM vs. Fc 4/5 vs Fc 5/6 vs. Fc 6/7 vs Fc  
TBA TcO-PW11O39 N1114 NTf2 -1832/-1365 mV -587 mV 633 mV 1384 mV 
TBA TcO-PW11O39 TBA PF6/ACN -2000 mV -1100 mV 450 mV   1350 mV 
TBA TcN-PW11O39 N1114 NTf2 -1832/-1361 mV  -39.5 mV 1068 mV 
TBA TcN-PW11O39 TBA PF6/ACN -2000 mV N/A -600 mV 850 mV 
TBA TcNCl4 0.1M TBA PF6/ACN N/A N/A -197 mV  
TBA TcNCl4 0.1M N1114 NTf2/ACN N/A N/A -161 mV  
TBA TcNCl4 0.1M TBA PF6/CH2Cl2 N/A N/A -252 mV  
TBA TcNCl4 N1114 NTf2 N/A N/A 86 mV  
Figure 5.5 Shows the voltammograms of TBA TcO-PW11O39 in ACN/TBA PF6 (black) (25 nM in 0.1M TBA 
PF6/ACN) and the ionic liquid (red) (adhered to the surface of the electrode) scan rate 100mV/sec(A) and TBA 
TcN-PW11O39 in ACN/TBA PF6 (black) (25 nM in 0.1M TBA PF6/ACN) and the ionic liquid (blue) (adhered to the 
surface of the electrode) scan rate 100mV/sec (B) 
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5.3.1.5 TcNCl4 vs. TcNPOM 
The 5/6 redox couple is the only couple which can be directly compared as it is exists in 
both TcNCl4- and the TcNPOM. This redox couple was studied in two solvent systems, TBA 
PF6/ACN and N1114 NTf2 for both Tc complexes (Figures 5.4 and 5.5). In acetonitrile, the 5/6 
redox couple in the TcNCl4- complex (Figure 5.4 D) appears at -196 mV, while this same couple 
appears at -600 mV in the TcN-POM complex (Figure 5.5). The difference in redox potential 
implies that the TcNCl4- is more labile. This difference also attests to the ability of the POM to 
stabilize the Tc-nitrido core. In the ionic liquid, the 5/6 redox couple appears at +86 mV and -40 
mV in the TcNCl4- and the TcN-POM respectively. Once again, the IL facilitates the reduction of 
both compounds.  
5.3.1.6 Comparison of Tc POM in ionic liquid vs. TBA PF6/ACN:  
In the IL system N1114 NTf2, there is a general positive shift of all redox couples in 
comparison to the acetonitrile system (see Table 5.1). The magnitude of the shift is dependent 
upon the redox couple, the 5/6 redox couple is shifted by +133 mV in the TcO-POM and by 
+640 mV in the TcN-POM. The 6/7 redox couple also shifts but not as drastically. The 6/7 redox 
couple shifts by +34 mV in the TcO-POM and by +218 mV in the TcN-POM. The positive  shift 
in the redox behavior of an analyte in an IL has been observed before; the shift in redox potential 
may be the result of the higher stabilization of the ion generated at the electrode and the cation of 
the IL through electrostatic interactions.134 This positive shift in potential may enable us to 
observe oxidations and reductions that were not previously observed in the organic solutions. 
This is useful because we may be able to reduce high-valent technetium under standard 
conditions this may take less energy and might not require the use of acid.  
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5.3.2 Electrochemical Dissolution in ionic liquids:  
In an effort to better understand the process of electrodeposition of technetium metal, we 
set out to study pure Tc0 metal and its speciation upon electrodissolution. In this study, a 
technetium metal electrode was electrochemically dissolved into an ionic liquid. Upon 
dissolution, UV-Vis and CV analysis were performed to identify the technetium species formed. 
These experiments were conducted using a polished technetium metal electrode that was 
prepared at UNLV, and commercially obtained trimethylbutylammonium bistrifylimide 
(Solvionic).  
Figure 5.6 shows the technetium electrode (left) and its dissolution in the IL. First, cyclic 
voltammetry using the technetium electrode was conducted to determine the optimal voltage for 
dissolution.  There was observation of a sharp increase in current at 900 mV, so this potential 
was chosen to be the dissolution potential. Bulk electrolysis was then performed at 900 mV for 
2-8 hours. After bulk electrolysis, the technetium electrode was removed, and a gold electrode 
was used to perform cyclic voltammetry on the solution. 
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Figure 5.6. Technetium electrode and electrode dissolution in IL 
 
The CV of the IL after the electrochemical dissolution of the technetium metal, measured 
using a gold electrode (Figure 5.7A), looks similar to that of TcO4- in the wet ionic liquid 
(Figure 5.3) and like that figure, the speciation has yet to be determined. The UV-Vis spectrum 
of the same solution shows the characteristic absorbance bands of TcO4- but also exhibits a broad 
absorbance that peaks around 500 nm (Figure 5.7 B). The electrode was also electrochemically 
dissolved in an acidic IL. A 50 mM solution of HNTf2 in N1114NTf2 was used to dissolve the 
electrode under the same conditions as the neutral IL. Figure 5.8 shows The CV and the UV-Vis 
of IL solution after dissolution of the technetium metal in 50 mM HNTf2 using a gold electrode 
(Figure 5.8A) shows a large increase in current (overpotential) around -600 mV. This is likely 
due to the interaction of the gold electrode with the acid protons.147 The over potential makes it 
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difficult to identify any technetium species in solution. The UV-Vis spectrum shows peaks that 
resemble pertechnetate and another unidentified species which is believed to be pertechnic acid 
(HTcO4). (Figure 5.8B)  
These results suggest that the technetium metal is oxidized to TcO4-. Voltammetry of the 
neat ionic liquid using a gold electrode determined that trace amounts of water were present in 
the ionic liquid. The trace water most likely led to the formation of the highly favored TcO4- ion, 
which is difficult to reduce back to the metal. In essence, the bare Tc2+ ion could not be produced 
and plated back onto the metal. Future work may focus on task specific ionic liquids that may be 
able to solvate a bare Tc ion. A bare Tc ion would be easier to reduce, as there aren’t any ligands 
to remove during the reduction.  
 
 
 
Figure 5.7.Cyclic voltammogram (A) and UV-VIS spectra (B) of the IL solution after the dissolution of the technetium 
metal electrode 
  
 
A B 
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Figure 5.8. Cyclic voltammogram (C) and UV-Vis(D) of the IL with 50 mmol HNTf2 after the dissolution of the 
technetium metal electrode   
 
5.4 Conclusion 
An initial investigation into the speciation and electrochemistry of technetium in ionic 
liquids has been conducted. From the study of simple technetium complexes, we have gained 
valuable knowledge about the behavior of technetium in ionic liquids. From our study of TBA 
TcO4, we have found that in N1114 NTf2, TcO4- will only be reduced in the presence of protons. 
From our study of TBA TcNCl4 we found that the IL facilitates the reduction of the 5/6 redox 
couple and that this reduction is an effect of the bulk material rather than the specific cation and 
anion which make up the IL. From our POM studies we have found that the IL may shift the 
redox potential of both technetium and tungsten, which demonstrates that the facilitation of 
reduction in this system is not unique to technetium. We have also found that a low water content 
is crucial for effectively conducting any dissolution studies of Tc metal. The presence of water 
leads to the formation of technetium oxide complexes that are hard to reduce, and thus it would 
prevent technetium from electroplating. In order to make an attempt at depositing technetium 
  
 
A B 
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from ILs, experiments must be conducted in a dry, oxygen-free environment. We have also 
found that the ionic liquid shifts the potential of all the redox processes studied in the positive 
direction. This is useful because using ILs, we may be able to reduce technetium under gentler 
conditions i.e with a lower potential and without the use of acids.  
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6. Conclusion 
This work sought to utilize fundamental chemistry principles to address complicated real-
world problems with simple chemistry. By applying fundamental chemistry principles like hard-
soft acid base theory and solubility we were able to identify alternative methods of separation 
and probe a new field of chemistry.  
The debulking studies of thorium using polyoxometalates (POMs) were highly successful 
on many accounts (Chapter 2). First, the extractions separate the Th and Ac: over 90% of 
thorium was extracted into the organic layer, leaving more than 90% of actinium in the aqueous 
solution. Second, this work exploited the coordination chemistry of thorium using the well-
defined polyoxometalate donor atoms to create highly stable Th POMs that will extract into the 
organic phase. The reported stability constants of Th POMs with lanthanide POMs track well 
with the extraction data. This extraction method may be a proof of concept, but it is a new 
approach to the debulking of thorium targets. Other works have shown that the extraction of 
thorium can be carried out under very acidic conditions using ion exchange resins.24-26 This work 
may have to serve only as a proof of concept and not progress towards deployment because of 
the availability and solubility of the POMs. However, the coordination chemistry and the “fit” of 
the Th into the POM defect site may bode well for the design of new solid-state materials for 
separations of Th from Ac and lanthanides.  Future work may also focus on using commercially 
available POMs and perhaps different organic solvents that may be less toxic to the body.  
In the thorium-227 radiolabeling project (Chapter 3), we examined the effect of 227Th 
purity on the radiolabeling yields and we examined labeling with two different ligands, the 
universally used DOTA ligand and HOPO. The purity of thorium-227 has a huge effect on the 
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labeling yields. 227Th decays to 223Ra that in turn decays to daughters, including lead. Lead can 
exist in the +4-oxidation state and compete with 227Th for the ligands. This means as 227Th is 
decaying over time it is generating its own competitors. To eliminate the competing daughter as 
well as to cut down the potential dose from 223Ra, the thorium must be purified before use. We 
also found that HOPO appears to be a better ligand for coordinating thorium in a stable fashion, 
according to our stability studies. Both ligands are octadentate, and the preferred coordination of 
thorium is eight. However, thorium is also oxophilic and HOPO donates eight oxygen atoms 
while DOTA donates only four oxygen atoms as well as four nitrogen atoms. The issue of the 
daughters competing with the parent isotope for labeling is only one step in the investigation of 
thorium-227 as an isotope for targeted alpha therapy. The stability of Th-complexes in vitro and 
in vivo must also be examined. It is imperative to examine the stability in vivo because of reports 
of thorium-227 toxicity. The toxicity may be the result of thorium and radium depositing in the 
bone. The deposition of thorium into the bone may actually be advantageous. Since thorium is 
oxyphilic it is a bone seeker by nature, thorium-227 may be very efficient at killing tumors on 
the bones. It would be advantageous to investigate the potential use of thorium for the treatment 
of bone cancer. 
This work also probes the chemistry of technetium-99 in ionic liquids (ILs) to develop a 
fundamental understanding of the behavior of technetium in ILs in order to address the real-
world problem of nuclear waste storage. The chemistry underlying the application of ILs as a 
tool for separation of Tc from nuclear waste and storage was examined in two parts: part one 
examined the electrochemical behavior of technetium in ionic liquids and part two explored the 
reactivity of technetium in ILs. The overall goal was to test the feasibility of using ionic liquids 
for electrodeposition of Technetium-99. To our knowledge the electrochemical behavior and 
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speciation of technetium in ILs has never been reported. In order to gauge whether or not this is a 
fruitful direction, this study was conducted. From our studies we found that pertechnetate and 
other technetium compounds are more easily reduced, and pertechnetate is reactive towards acid 
in ionic liquids. This has been a common theme in ionic liquid electrochemistry. It has been 
shown that the reductions of other metals have been facilitated in ILs.15, 105, 127, 132, 134, 148-149 Our 
work found facile reduction in ILs compared to organic solvents, and this shows promise for the 
reduction of Tc-99. Our work also explored the reactivity of technetium in ILs. Typically, the 
protonation of pertechnetate occurs using high concentrations of sulfuric acid. In ILs, 
pertechnetate is pronated using very low concentrations of acid. EXAFS AND XANES data 
show that over time, technetium reacts with the typically inert anion of the IL. Further studies are 
needed to identify the species that is formed during this process. Understanding the speciation 
and behavior of technetium in ILs will provide a considerable amount of insight into the 
extraction an electrodeposition of technetium. The study of technetium in ionic liquids has really 
only just begun. This works served as a starting point for the field of technetium chemistry in 
ILs. The effects of different acids on the behavior of pertechnetate must also be explored The IL 
for the studies was specifically chosen because inert and generally doesn’t react with IL, it would 
be also of interest to examine the behavior of Tc in an IL which is not as innocent. For example, 
protic ILs may be able to facilitate the reduction of pertechnetate. There are many avenues to 
explore in this field hopefully this work will be able to provide some insight along the way.  
In the early decades of technetium chemistry,  experiments were carried out in an effort 
to understand the coordination chemistry and overall behavior of technetium in aqueous and 
organic solutions. Experiments that examined the redox behavior and the coordination chemistry 
eventually lead to the understanding of specific Tc complexes that could be used in the clinic for 
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medical imaging with 99mTc. These early coordination chemistry studies coupled with the 
availability of the 99Mo/99mTc generator led to technetium-99m being the most widely used 
isotope from medical imaging.  
In a similar fashion, the Tc research reported in Chapters 4 and 5 explores the Tc redox 
and coordination chemistry in a different media, ionic liquids. While this work may not 
contribute to identification of Tc-99m complexes for imaging, understanding the fundamental 
chemistry of technetium-99 in ILs may contribute to the design of important ligands, extractants, 
and reaction procedures, etc. for Technetium-99 and other isotopes.  
Overall, by employing fundamental principles we were able to examine alternative 
methods of manipulating actinium, thorium and technetium which had not previously been 
examined. Hopefully, this work has demonstrated that solutions to complicated real-world 
problems can be addressed by fundamental studies of the elements.   
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